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ABSTRACT

RISK FACTORS CONTRIBUTING TO THE DEVELOPMENT OF
BRONCHOPULMONARY DYSPLASIA AMONG PRETERM INFANTS
December 2020
Caitlin E. Bradley, B.S.N., University of Massachusetts Boston
M.S., Northeastern University
Ph.D., University of Massachusetts Boston

Directed by Associate Professor Teri Aronowitz

Bronchopulmonary dysplasia (BPD) is a pulmonary disease that effects infants born < 32
weeks gestational age. Despite improved survival among preterm infants, the incidence
and severity of BPD has not improved, rather the features and severity of BPD have
evolved (Abman et al., 2017). BPD is a disease that has significant impact on the
outcomes of preterm infants, including poor pulmonary and neurodevelopmental
outcomes (Abman et al., 2017). Since its identification in 1967, and many iterations to its
defining criteria, healthcare practitioners are unable to accurately predict infants’ risk of
developing BPD. Further, there is significant family, social, and economic impacts from
BPD. This dissertation research examined risk factors for BPD, as identified in a midrange theory developed from a systematic review of the literature. This mid-range theory
is framed using the Neuman Systems Model (NSM) (2011). The research utilized a
secondary analysis of data from a database including a cohort of infants born at < 32
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weeks’ gestation (n=455) treated at Boston Children’s Hospital. Findings from this
research demonstrated that multiple intrapersonal risk factors are associated with
development of BPD and the grades of BPD severity including gestational age, birth
weight, surfactant administration, necrotizing enterocolitis, infections, mechanical
ventilation duration, and patent ductus arteriosus. This research adds to the current body
of research by demonstrating specific risks associated with BPD. Findings of this
research could be used to identify maternal infant dyads that would benefit from early
therapy(s) to reduce BPD risk.
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CHAPTER I
INTRODUCTION

Background and Significance
Bronchopulmonary dysplasia (BPD; see Table 1) is a chronic lung disease unique
to premature infants. The disease was first identified in 1967 among a group of primarily
preterm infants with the following characteristics: 1) diagnosed with respiratory distress
syndrome (RDS, see Table 2); 2) exposed to oxygen and/or trauma related to mechanical
ventilation; and 3) demonstrated evidence of persistent pulmonary disease at 28 days of
life (Northway, Rosan, & Portar, 1967). The initial diagnostic criteria for BPD included
persistent oxygen requirement and abnormal respiratory symptoms until ≥ 28 -30 days of
age, chest radiographic (CXR) findings including heterogeneous aeration, and (when
available) evidence of pathology throughout the airway and lungs on postmortem
examination (Northway et al., 1967). Among the 32 infants in the first observational
cohort the mean gestational age was ≥ 32 weeks’ gestation. For those diagnosed with
BPD in this cohort, the mortality rate was significant as 19 of the 32 infants did not
survive (Northway et al., 1967).
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There were significant improvements in the care of preterm infants since 1967.
The improvements that had major impacts on the pulmonary health for preterm infants
included antenatal steroids, postnatal surfactant administration, and gentle ventilation
techniques. These will be discussed further in this paragraph. In the 1970’s,
administration of antenatal steroids to mothers experiencing preterm labor was examined
as it was hypothesized to reduce the incidence of RDS by releasing endogenous
surfactant facilitating lung maturity, (Liggins & Howie, 1972). During the trial in 1972
(Liggins & Howie, 1972), infants whose mothers received antenatal steroids had
significantly less RDS than those in the control group. Since the 1970’s, antenatal steroid
administration for mothers in preterm labor is standard of care. Surfactant, a lipoprotein,
increases in production in the final trimester of pregnancy and works to reduce
pulmonary surface tension allowing for improved gas exchange. Typically, present in
adequate amounts in full term infants, surfactant is deficient in preterm infants. This
deficiency increases the risk for RDS (Halliday, 2008). Exogenous surfactant (see Table
2) trials during the mid-to-late 1980’s demonstrated evidence that administration of
surfactant during the first hours to days of life decreased the incidence of RDS and
improved the survivability of preterm infants. The United States Food & Drug
Administration (FDA) approved the use of exogenous surfactant for the treatment of RDS
in 1990 (NORD, 2004). Following approval of surfactant, gentle ventilation techniques
became routine, leading to less pressure-induced lung damage (Ehrenkranz et al., 2005;
Jobe & Bancalari, 2001). Yet, despite these interventions and improvements in the care
of premature infants the incidence of BPD did not decrease. While more infants survived
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at younger gestational ages, improved survival led to a new, more complex form of BPD
termed “new BPD” (Abman et al., 2017).
The initial hallmark of BPD was heterogeneous lung expansion, demonstrated on
CXR and consistent with surfactant deficiency (Northway et al., 1967). Findings
associated with the “new BPD” are more complicated and hallmarked by arrested lung
development (Jobe & Bancalari, 2001). To account for the changing population of
preterm infants and the evolving pathology of BPD, the diagnostic criteria created in
1967 and edited minimally through the subsequent years needed to be adapted. The
accepted criteria for grading BPD, still used today, was decided upon at a workshop
attended by the members of the National Institute of Child Health and Human
Development (NICHD), the National Heart, Lung, and Blood Institute (NHLBI), and the
Office of Rare Diseases (ORD) in 2000. These governing institutes/offices determined
time points and respiratory support requirements demarcating diagnostic criteria for the
grading of BPD (see Table 1). The diagnosis of BPD is made at 36 weeks’ postmenstrual
age ([PMA] see Table 2) and is based on the need for oxygen delivered by a nasal
cannula, non-invasive ventilation, or invasive ventilation at 28 days, as originally
proposed by Shennan, Dunn, Ohlsson, Lennox, & Hoskins (1988). The new criteria
proposed in 2000 added grading (i.e., mild, moderate, and severe BPD [see Table 1])
(Jobe & Bancalari, 2001) to account for the differing severity in BPD presentation and
symptoms. The risks, costs, and outcomes for infants becomes more complicated as BPD
severity increases.
These new diagnostic criteria were validated in a research study examining the
outcomes of 4866 infants born at < 32 weeks’ gestation. When this cohort of preterm
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infants was assessed between 18-22 months in follow-up clinics, the new BPD criteria
was shown to be effective at identifying infants with abnormal pulmonary symptoms at
28 days and 36 weeks’ PMA. Further, this criterion was effective at identifying those
infants with a higher risk for pulmonary and neurodevelopmental sequelae up to their 1822-month assessment in follow up clinic (Ehrenkranz et al., 2005).
There are recognized risk factors that are related to the development of BPD,
especially severe forms of BPD. The most significant risk factor is preterm birth in that
there is an inverse relationship between gestational age at birth and the incidence of BPD.
Strong associations for the development of BPD include male sex and duration of
mechanical ventilation (Abman et al., 2017). Additionally, certain postnatal conditions
are associated with an increased risk of developing BPD (i.e., patent ductus arteriosus,
sepsis, and necrotizing enterocolitis requiring surgery) [see Table 2] (Abman et al.,
2017). Other proposed risks, some controversial, include race/ethnicity and
chorioamnionitis, an intrauterine inflammatory and infectious process. Laughon et al.
(2011) developed a tool to evaluate the risk of BPD development among preterm infants.
This tool employs some of the risks found in the literature. However, with continual
evolution of the preterm infant population, reevaluation of risk must be conducted.
Infants born at < 32 weeks’ gestation represent only 1.6% of the total births in the
United States (Martin, Hamilton, Osterman, Driscoll, & Matthews, 2017). BPD is a rare
disease compared to other childhood illnesses but is one of the most common morbidities
among infants born at < 32 weeks’ gestation (Abman et al., 2017). The clinical course of
infants with BPD is complicated by multiple comorbidities. These morbidities include
neurodevelopmental impairment, extrauterine growth restriction (EUGR), pulmonary
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hypertension, gastroesophageal reflux, feeding issues, retinopathy of prematurity, and
systemic hypertension (Abman et al., 2017; Glass et al., 2015; Gou, Yang, & Xiao, 2018)
(see Table 2). These complications become worse as BPD severity increases. As a result
of the morbidities this multisystem disease is considered a significant challenge for
healthcare providers as well as the families.
Despite identification of BPD more than 50 years ago as well as multiple
iterations of the diagnostic criteria, there has been no improvement in the incidence,
morbidity, or mortality rates since the adoption of the criteria in 2001 (Abman et al.,
2017). There are several grades of BPD, each with associated prevalence in the
population of infants born at < 32 weeks’ gestation: no BPD (23.1%), mild BPD (30.3%),
moderate BPD (30.2%), and severe BPD (16.4%) (Ehrenkranz et al., 2005). Despite
reduction efforts, the incidence and severity of BPD has not changed since 2005 (Abman
et al., 2017). One conservative estimate is that 2,000 infants and children require home
ventilation in the United States due to BPD (Abman et al., 2017). Mortality related to
BPD is similarly not well understood, as cause of death for those infants could also be
attributed to prematurity, respiratory failure, and comorbidities such as pulmonary
hypertension.
The economic impact of BPD is unknown but is considered one of the most
expensive morbidities of prematurity (Johnson, Patel, Jegier, Engstrom, & Meier, 2013;
Lapcharoensap, Lee, Nyberg, & Dukhovny, 2018). Another significant barrier to cost
estimates is that most reports only evaluate the cost of neonatal intensive care
hospitalization. BPD, especially more severe forms of BPD, has many additional costs
beyond the NICU such as the cost of specialty services, tracheostomy placement, in-
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patient rehabilitation, home care, durable medical equipment, home medication,
outpatient providers, and rehospitalization (Abman et al., 2017). These costs incurred
post NICU hospitalization are not included in economic estimates. Further, chronic
morbidities such as neurodevelopmental impairment increases lifetime healthcare costs
but is not included (Abman et al., 2017; Lapcharoensap et al., 2018).
One estimate for the cost of BPD is an additional average cost of $31,565 above
the costs incurred during neonatal intensive hospitalization. This cost increased as birth
weight decreased (cost ranging $19,970 for larger preterm infants to $43,312 for smaller
infants; Johnson et al., 2013). A more encompassing estimation of costs included care
during NICU hospitalization and associated morbidities, cumulating to a median cost of
$102,000 for infants with BPD (Lapcharoensap et al., 2018). In contrast, the cost of
hospitalization for uncomplicated full-term newborns is $500, and $36,800 for an
uncomplicated infant born at < 28 weeks’ gestation (Lapcharoensap et al., 2018). These
cost estimates do not account for lost productivity or wages of either caregivers or those
with BPD. Reports on the societal impact for BPD are sparce, but significant. From a
psychologic perspective, mothers of infants with BPD are more likely to have significant
postpartum depression than those without BPD (Brady, Zhang, Kirpalani, & DeMauro,
2019; Moura et al., 2017). BPD is a diagnosis that poses great challenges to the patients
and their families from a psychological and economic perspective.
The care for preterm infants has changed significantly and so have the limits of
viability, thus younger preterm infants are surviving. BPD is no longer a sequalae of
surfactant deficiency. The “new BPD” is characterized by an arrest in lung development,
simplified alveoli, and reduced pulmonary microvasculature (Abman et al., 2017).
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Societal and economic impact is significant with BPD, especially as the severity of BPD
increases (Abman et al., 2017; Johnson, Patel, Jegier, Engstrom, & Meier, 2013;
Lapcharoensap, Lee, Nyberg, & Dukhovny, 2018). While BPD is a rare outcome
considering all other childhood illnesses, it has significant health, economic, and societal
costs. The purpose of this study is to examine the risk factors for BPD as identified in
the developed mid-range theory. The variables in this mid-range theory can be used to
identify infants at risk for BPD. Further, understanding the stressors and identifying
infants at risk may lead to risk reduction and treatment strategies that can be targeted to
prevent BPD.
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CHAPTER II
LITERATURE REVIEW

Impact of BPD on Families and Society
Less than two percent of infants in the United States are born at < 32 weeks’
gestation (Martin et al., 2017). While BPD is a rare disease among all children, it is a
common diagnosis for infants born at < 32 weeks (Abman et al., 2017). Of infants born at
< 32 weeks’ gestation 76.9% are diagnosed with BPD (Ehrenkranz et al., 2005).
A diagnosis of BPD increases the cost of neonatal intensive care hospitalization
by an average of $31,565, for each infant. When NICU hospitalization and associated
morbidities were combined, the median hospital costs for infants with BPD were
$102,000 (Lapcharoensap et al., 2018). Lost productivity and wages for caregivers are
not included in these estimates. There are also scant although important reports on the
societal impact of BPD. From a psychologic perspective, mothers of infants with BPD
are more likely to have higher rates of postpartum depression and poorer perceived
quality of life than mothers whose infants do not have BPD (Brady, Zhang, Kirpalani, &
DeMauro, 2019; Moura et al., 2017).
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Historical/Sociological/Political/Economic aspects
Kingdon (2011) described the convergence of three streams (problem, politics,
and policy) as the means to address a political agenda. Prior to the 1960’s the morbidity
and mortality of preterm infants was staggering. Health care professionals and
researchers were working to improve the survivability of preterm infants. Advancing the
care of preterm infants became a national priority with the death of President John F.
Kennedy’s son who died as a result of his premature birth in 1963 (Altman, 2013).
Patrick Kennedy was born prematurely at almost 35 weeks’ gestation and suffered from
RDS. RDS is caused by a lack of surfactant in the lungs, which leads to reduced
pulmonary surface tension and causes significant difficulty with ventilation and
oxygenation (Altman, 2013; Halliday, 2008). In 1963 only supportive care could be
offered for RDS. Unfortunately, he died at two days-of-life.
After Patrick’s death the political climate was right to advance the political and
research agenda to improve the care for preterm infants, by increasing National Institutes
of Health funding (Halliday, 2008). One of the most important advances was the
administration of exogenous surfactant to treat RDS (Halliday, 2008). Clinical trials
were conducted in the 1980s and surfactant was approved by the FDA in 1990 for the
treatment of RDS (NORD, 2004). Administering surfactant to preterm infants is now
standard of care. Were Patrick Kennedy to have been born today, administration of
exogenous surfactant would have near guaranteed his survival. The political climate of
the early 1960’s was an ideal environment for this convergence to change the policies and
practices involved in the care of preterm infants. Legislators and healthcare personnel
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were motivated by prematurity and cognitive impairment (problems), which led to
political action and ultimately a change in health care policy.
Conceptual Framework
The conceptual model guiding this dissertation is the Neuman Systems Model
(NSM) (2011), a holistic systems approach. The aim of NSM is to reduce stress factors
and adverse conditions which either affect or could affect optimal functioning in a client
population (Fawcett & Neuman, 2011). The stressors that affect a given client population
can be viewed as extrapersonal (occurring outside the individual), interpersonal
(occurring between one or more individuals), and intrapersonal (occurring within the
individual) (Fawcett & Neuman, 2011). The goal of the individual is to achieve
homeostasis to adequately cope with the stressors and/or regain their optimal state of
health following a reaction to a stressor. In regard to the development of BPD, many
stressors have been identified in the literature.
A systematic review of the literature was conducted to identify the most
influential risk factors that leads to the development of BPD. Employing the NSM, these
factors were categorized by extrapersonal, interpersonal, and intrapersonal stressors.
Extrapersonal stressors are represented by maternal race/ethnicity and genetics, including
the sex of the neonate. In the literature the role of maternal race/ethnicity in BPD
development was conflicting and found to be both a risk for BPD and a protective factor
against BPD development (Janevic et al., 2018; Lapcharoensap et al., 2015). The
interpersonal stressors represented prenatal risks of inflammation, infection, and maternal
vascular underperfusion (e.g., chorioamnionitis). Finally, intrapersonal stressors are
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represented by risk within the premature infant that requires intervention(s) and care in
the NICU (e.g., surfactant administration).
Chronic exposure to racism experienced by Black Americans is also known as an
allostatic load (Alhusen, Bower, Epstein, & Sharps, 2016; Bediako, BeLue, & Hillemeier,
2015; Scott, Britton, & McLemore, 2019). This allostatic load can manifest as
physiologic alterations. Racism and allostatic load affect each of the stressors in the
NSM. This research will test a mid-range theory developed from the systematic review
focusing on the extrapersonal, interpersonal, and intrapersonal stressors contributing to
the development of BPD among infants born at < 32 weeks’ gestational age. The review
of studies that focused on risk factors in the development of BPD showed an
interrelationship between the three stressors of the NSM (see Figure 1).
The confluence of extrapersonal and interpersonal risks can culminate into
premature delivery, leading to a decrease in the number of alveoli, and reduction in
pulmonary microvascular development (Abman et al., 2017). Preterm birth introduces
postnatal risks, thus continuing lung development arrest, and solidifying the pathway to
BPD. While intrapersonal risks do not initiate the process of alveolar simplification or
pulmonary microvascular development reduction, they continue the pathogenesis towards
the development of BPD through premature delivery of the infant. Inflammation,
infection, poor growth, and associated adverse events all contribute to the compounded
risk for BPD (Abman et al., 2017).
Infants that have insults or risks in each of the stressors in this midrange theory
are hypothesized to be at highest risk for BPD development when compared to preterm
infants of the same age without similar risks. Following testing of this midrange theory,
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it may be used to identify infants at risk and lead to risk reduction and treatment
strategies that can be targeted towards these high-risk infants to prevent BPD. The
following discussion describes in more detail all the stressors within the mid-range theory
that are predicted to increase the likelihood of the pathogenesis of BPD. The NSM will be
employed to describe and organize the stressors.
The normal line of defense represents the usual health state of the client system
(i.e. patient) (Fawcett & Neuman, 2011). Testing this mid-range theory of BPD risk could
lead to the development of interventions that could act as the flexible line of defense to
decrease the risk of BPD. Infants with BPD have health ramifications that worsen as BPD
severity increases. Some ramifications of more severe BPD include pulmonary
hypertension, poor growth, and neurodevelopmental impairment (Abman et al., 2017).
Therefore, grading is used to indicate the presence and types of BPD.
Extrapersonal Stressors
Extrapersonal stressors in the NSM are distal to the client (Fawcett & Neuman,
2011). In the mid-range theory, these stressors are represented by preconception factors
and include genetic/epigenetic factors including sex of fetus, maternal sociodemographic
factors, and allostatic load.
Sex
Male sex has been associated with BPD since its first identification (Northway et
al., 1967). Data demonstrates diminished biosynthesis of androgen, a higher density of
androgen receptors, a decreased metabolism of androgen, and decreased degradation of
estrogen among male infants that developed BPD (Lal et al., 2018a). Furthermore, the
male fetus has a delayed surfactant production secondary to these sex/hormonal based
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differences, leading to increased resistance in the alveoli and control in the budding of the
bronchioles during early fetal development (Shim, Cho, Kong, & Park, 2017). This
knowledge provides insight into a sex-based hormonal mechanism increasing the risk for
BPD among male infants.
Genetic/Epigenetic Risks
Genome-wide association studies (GWAS) and deoxyribonucleic acid (DNA)
analysis have been used to identify genetic markers and/or variants that are associated
with BPD (Ambalavanan et al., 2015). To date there have been no conclusive gene(s)
identified that are associated with BPD. Further, genetic/epigenetic risk evaluations are
not consistently performed for all infants with BPD. Due to lack of standardization in the
incorporation of genetic/epigenetic evaluation in the routine care for infants with BPD,
genetic/epigenetic variables were not measured in this study and will not be further
discussed.
Race/Ethnicity and Preterm Birth
Preterm birth is the most significant risk factor for BPD. While the overall
incidence of preterm birth in the United States (U.S.) is 10%, the incidence of preterm
birth is 13% for Black Americans as compared to 9% for White Americans (CDC, 2016).
The etiology of this significant health disparity may be due to a complex interaction of:
1) racism and allostatic load and 2) maternal access/utilization/quality of health care
concerns (Alhusen, Bower, Epstein, & Sharps, 2016; Bediako, BeLue, & Hillemeier,
2015; Scott, Britton, & McLemore, 2019). Given the complexity of these issues each
will be discussed separately.
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Racism and Allostatic Load. Racism is defined as “unequal treatment stemming
from skin color or other individual characteristics” (Alhusen et al., 2016, p. 2). Allostatic
load is the effect(s) of chronic exposure to racism and the associated physiologic
alterations, including impaired immune function and increased inflammation (Giurgescu
et al., 2016; Olson et al., 2015). Biomarkers of allostatic load include cortisol, cytokines,
interleukin-6, and C-reactive protein; each of these are inflammatory mediators (Olson et
al., 2015). Among pregnant women, allostatic load is evidenced by an increase in
preterm birth, pre-eclampsia, fetal growth restriction, inflammatory disease, and more
(Alhusen et al., 2016; Giurgescu et al., 2016; Olson et al., 2015). Allostatic load has the
capacity to perpetuate the significant health disparity experienced by Black Americans in
immediate and subsequent generations through alterations in the inflammatory cascade
(Olson et al., 2015).
Prematurity is the most consistent risk factor for BPD. The incidence of
prematurity is higher among Black infants (CDC, 2016). However, the association of
race/ethnicity and risk for BPD is inconsistent in the literature; there is literature
supporting the role of race/ethnicity in BPD development as protective in Black neonates
(Lapcharoensap et al., 2015), as well as a potential risk for BPD development (Janevic et
al., 2018). The association between race/ethnicity, and BPD is complex and deserves
further exploration.
Access/Utilization/Quality of Health Care. Access to health care is a complex
process that ideally begins with preconception care. This is in relationship to the fetus’
environment during pregnancy. While approximately 50% of births and care up to 60
days following birth are covered by public insurance in the United States, comprehensive
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preconception care is not available to all pregnant women (Scott, Britton, & McLemore,
2019). Black women are more likely to be uninsured, thus are least likely to have access
to preconception care. This makes them more likely to have ineffective management of
any health conditions, should they arise, either during the pre-pregnancy or during
pregnancy (Scott et al., 2019). Also, a result of their lack of insurance and access to
healthcare they may be more likely to have under or undiagnosed chronic conditions for
which they will not have received health education and/or treatment.
The relationship between early prenatal care and improved obstetric and neonatal
outcomes, including reduction of preterm birth, have been well established (Daniels, Noe,
& Mayberry, 2006). However, many barriers still exist to receiving prenatal care
including lack of: 1) health insurance, 2) availability of providers, 3) time availability for
the mothers to attend lengthy appointments, 4) transportation to the appointments, and 5)
availability for the long wait times in clinics. These factors have all been reported as
barriers to prenatal care especially for Black women (Scott et al., 2019; McLemore et al,
2018). Twenty-two percent of Black mothers enter prenatal care late, whereas 15% of
White mothers have late entry (Bediako et al., 2015; Edmonds, Mogul, & Sheen, 2015;
U.S. Department of Health and Human Services, 2013).
Once able to access prenatal care, the four other factors that decrease prenatal
care, the availability of providers, transportation to prenatal care appointments, length of
wait times, and insurance status, continue to impact prenatal care. Black mothers cited
many barriers to accessing and maintaining prenatal care including; 1) insurance status;
2) understanding the Medicaid enrollment and eligibility; 3) lack of social support to
attend prenatal care appointments; 4) transportation to appointments; 5) long wait times
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in clinics; 6) ambivalence to pregnancy; 7) and having an unwanted pregnancy without
access to providers to discuss health care options (Daniels, 2006; Edmonds et al., 2015).
Issues within the provider and women relationship continue to impact prenatal
care for Black mothers. These issues include the lack of personal connection to their
provider, lack of continuity of care with providers, and disrespectful actions by health
care personnel. For example, Black mothers with public insurance perceived that clinic
staff were less responsive and respectful of them as compared to mothers with private
insurance (Salm, Mazul, Ngui, Bridgewater, & Harley, 2013). Public insurance was
perceived as a barrier to quality health care by impacting mothers’ options for hospitals
and choice of providers (Salm et al., 2013; Scott et al., 2019). Women who had public
insurance reported they felt they were viewed as less important by their providers and
subsequently these impressions by providers was shown to lead to substandard care
(Salm et al., 2013; Scott et al., 2019). Also, another research study found that Black and
Hispanic mothers were more likely to give birth at poorer performing hospitals. Infants
born at these poorer performing hospitals had higher morbidity and mortality rates as
compared to infants born at higher performing hospitals (Howell et al., 2018).
Less access to health care does not only impact the number of appointments that
Black mothers attend but also the prenatal education they receive due to a decrease in
provider encounters. Many behavioral factors have been well established as causing an
elevated risk for preterm birth especially in Black women. These behavioral factors
include diabetes (Cabacungan, Ngui, & McGinley, 2012; Scott et al., 2019), hypertension
(Cabacungan et al., 2012; Scott et al., 2019), sexually transmitted infections (STIs)
(Cabacungan et al., 2012) pre-pregnancy obesity (Bediako et al., 2015), smoking

16

(Bediako et al., 2015), and inappropriate weight gain during pregnancy (Cabacungan et
al., 2012). These conditions are impacted by the number of prenatal appointments and
amount of education received. Access, utilization, and quality of health care are
important contributing factors in preterm birth and potentially BPD development.
However, these details are not available in the database that will be used for this research
and they are not available in the Boston Children’s Hospital medical records. Therefore,
these data were not included in this research.
Interpersonal Stressors
Interpersonal stressors occur outside but proximal to the client (Fawcett &
Neuman, 2011). Interpersonal stressors in this study’s mid-range theory include prenatal
inflammation, prenatal infection, and maternal vascular underperfusion.
Prenatal Inflammation
A systematic review of the literature identified several inflammatory biomarkers
markers associated with the development of BPD. KL-6 is a high molecular weight
mucinous glycoprotein expressed by alveolar type II cells and bronchiolar epithelial cells
and is elevated in the setting of damage to the pulmonary epithelium and interstitium
(Kim et al., 2008; Ogihara et al., 2006). Interleukin-8 (IL-8) is another inflammatory
biomarker identified from the systematic review. IL-8 is a glycoprotein that regulates the
innate immune response, the adaptive immune response, and the growth/differentiation of
hematopoietic cells (Rocha et al., 2012). Biomarkers for fetal inflammation have been
associated with chorioamnionitis, a bacterial infection of the fetal membranes that also
leads to inflammatory changes present in the mother and the fetus. Biomarkers are not
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routinely collected in the NICU, so they are not routinely reported in the database or the
Boston Children’s medical record and will not be a focus of this research.
Clinical methods to detect histologic chorioamnionitis were consistently
performed according to the method outlined by Redline (2006), where a pathologic
evaluation is completed to diagnose both maternal and fetal acute and chronic
inflammation (Mestan et al., 2014). More specifically, for acute maternal inflammation, a
neutrophil infiltration of the chorion, amnion, and at its most severe, necrotizing
chorioamnionitis is evident (Redline, 2006). Chronic inflammation involves neutrophilic
infiltration of the chorionic villi, intervillious space, and/or basal plate; this demonstrates
inflammation with placental involvement (Redline, 2006). These biomarkers associated
with chorioamnionitis are associated with damage to the lungs, immune system, and even
growth/differentiation of hematopoietic cells (Kim et al., 2008; Ogihara et al., 2006;
Rocha et al., 2012).
Prenatal Infection
Infection initiates an inflammatory process. Like antenatal inflammation,
antenatal infection is a risk for BPD because of the resulting changes in lung surfactant
composition, potentiation of the alveolar and vascular simplification, and contribution to
the imbalance between pro and anti-angiogenesis (Thekkeveedu, Guaman, & Shivanna,
2017). Biomarkers for infection were represented by positive bacterial culture results and
were associated with IL-8 (like inflammation). One bacterial organism associated with
BPD is ureaplasma (Inatomi et al., 2012). In the literature, antenatal infection is
clinically represented by chorioamnionitis. Histologic chorioamnionitis was described
above. Clinical chorioamnionitis (CC) is diagnosed by one of two methods, either by
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placental pathology or by maternal clinical signs and symptoms indicative of
chorioamnionitis (American College of Obstetricians and Gynecologists, 2017; Arayici et
al., 2014; Ballard et al., 2016; Kibel et al., 2016; Lee et al., 2011; Mestan et al., 2014;
Redline, 2006; Solimon et al., 2017). Both diagnostic methods necessitate presence of a
maternal fever (Arayici et al., 2014; Ballard et al., 2016; Kibel et al., 2016; Lee et al.,
2011; Solimon et al., 2017). Depending on the source, either one or more of the
following signs must be present for CC to be diagnosed: maternal tachycardia, fetal
tachycardia, uterine tenderness, malodorous amniotic fluid, leukocytosis, and/or elevated
C-reactive protein. The criteria from the American College of Obstetricians and
Gynecologists (ACOG) uses the more conservative approach when diagnosing CC;
maternal fever and at least one other clinical sign (Ballard et al., 2016; ACOG, 2017).
Criteria for diagnosing histologic chorioamnionitis (HC) is based on a pathological exam
of the placenta. When diagnosing HC there must be infiltration of neutrophils into the
amniotic membranes, the umbilical cord, or the chorionic plate (Arayici et al., 2014;
Durrmeyer et al., 2012; Lee et al., 2011; Redline, 2006; Solimon et al., 2017; Yum et al.,
2018). HC and CC are diagnoses consistent with infection. HC and/or CC is acceptable
to use to diagnose chorioamnionitis in clinical practice.
Maternal Vascular Underperfusion
Maternal vascular underperfusion (MVU) is defined by pathological changes to
the placenta that can cause fetal growth restriction and increase risk for BPD and BPD
associated pulmonary hypertension (Mestan et al., 2014; Mestan et al., 2017). The
mechanism for BPD development among preterm infants whose mothers had
hypertensive disorders is thought to be related to an imbalance of pro- and anti-
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angiogenic factors. This disparity in angiogenic factors is believed to cause abnormal or
insufficient vascular and alveolar pulmonary development (Dravet-Gounot et al., 2018).
There are many biomarkers associated with MVU identified from a systematic
review of literature. Some of the biomarkers were the same as ones associated with
inflammation and infection, such as KL-6 and cytokines. Other factors were unique to
MVU were either pro or antiangiogenic (i.e., endothelin-1, fibroblast growth factor-10,
and tumor necrosis factor) (Baumann et al., 2015; Janer, Andersson, Haglud, Karikoski,
& Lassus, 2008; Kim & Kim, 2014; Kim et al., 2008; Kim, Shin, Kim, & Kim, 2018;
Mohamed et al., 2014; Ogihara et al., 2006; Rocha et al., 2012.
MVU can be diagnosed clinically and/or pathologically. Clinically, MVU
presents as maternal hypertensive disorders such as gestational hypertension,
preeclampsia, HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet
count), and/or eclampsia [see Table 2] (ACOG, 2002; Solimon et al., 2017; Torchin et al.,
2016). The criteria for diagnosing maternal hypertensive disorders was consistent across
the literature and are the basis of the ACOG guidelines (ACOG, 2002). Criteria for
pathologic evaluation of MVU was also consistent across all the studies specifically,
vasculopathy of the parietal and basal decidua. MVU is graded as either mild or severe,
depending on the number of lesions visualized (Redline et al., 2004). Maternal
hypertensive disorders (chronic hypertension, gestational hypertension, preeclampsia,
HELLP syndrome) are the empiric indicator for MVU in this research.
Fetal growth is associated with BPD thus birth weight is a critical measure to
assess as it may be indicative of poor fetal growth (Charles et al., 2019). Further, fetal
growth restriction (FGR) is associated with maternal vascular underperfusion, which is a
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risk factor for BPD development. Infants with FGR experience a higher incidence and
severity of BPD. FGR, small for gestational age, and intrauterine growth restriction are
all synonymous in the literature and are defined as growth <10th percentile based on fetal
growth curves (El Ayoubi et al., 2016; Nyp et al., 2015; Ozkan et al., 2012; Tsai et al.,
2015). FGR will be used as the empiric indicator for this research.
Intrapersonal Stressors
These stressors are measured and/or occur postnatally within the premature infant.
Infant characteristics include gestational age, birth weight, inflammation, infection,
patent ductus arteriosus, and EUGR requiring interventions delivered in the NICU. These
NICU interventions include doses of surfactant, number of transfusions of packed red
blood cells, duration of mechanical ventilation.
Infant Characteristics
Infant characteristics associated with BPD include demographics such as
gestational age and birth weight, postnatal inflammation and infection, patent ductus
arteriosus, and EUGR.
Gestational Age. A hallmark of BPD is an arrest of lung development; the earlier
the arrest, the less lung development has occurred at the time of birth. Further, the earlier
the gestational age at birth, the earlier the exposure to oxygen and mechanical ventilation
(Abman et al., 2017). This exposure to oxygen and mechanical ventilation injures
vulnerable, underdeveloped lungs. Gestational age, measured in completed weeks of
gestation, is inversely related to the incidence and severity of BPD and is multifactorial
(Abman et al., 2017). This relationship is multifactorial.
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The initial determination of gestational age commonly employed when
confirming pregnancy, is based using either the date of the last menstrual period (LMP)
and/or the estimate from a first trimester ultrasound (Binet et al., 2012; Dravet-Gounot et
al., 2018; Mestan et al., 2014; Torchin et al., 2016; Tsai et al., 2015). The Ballard exam
is a a systematic physical examination to assess preterm infants’ gestational age. It was
expanded in 1991 to include the assessment of gestational ages 20-44 weeks’ (Ballard et
al., 1991; Ozkan et al., 2012). This exam is most accurate when conducted in the first 96
hours of life and when compared with prenatal ultrasound, the New Ballard Score had a
correlation of 0.97 and inter-rater reliability of 0.95 (Ballard et al., 1991). While the New
Ballard is accurate, one limitation is that training is necessary to reliably complete the
exam. Additionally, the results of the Ballard exam can be affected by issues such as
sedating medications used during labor, sepsis, and neuromuscular disorders (Ballard et
al., 1991). Clinically, the Ballard exam is useful to estimate gestational age when it is
unknown, otherwise gestational age is most reliable when based on either LMP or
ultrasound.
Birth Weight. According to the literature, infants born at lower birth weight
have a higher risk for developing BPD. Further, infants with the lowest birth weights not
only have a higher risk for BPD, but of also developing more severe forms of BPD
(Dravet-Guonot et al., 2018; Guo et al., 2015). This relationship between BPD and lower
birth weight is in part due to the association between low birth weight and maternal
vascular underperfusion, and the relationship with an imbalance between pro and antiangiogenic factors (Dravet-Guonot et al., 2018).
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Fetal growth is a comprehensive and objective assessment of intrauterine growth.
Fetal growth is estimated during pregnancy, and then finalized with birth weight. Poor
fetal growth and low birth weight have many associated morbidities, including BPD (El
Ayoubi et al., 2016; Nyp et al., 2015; Ozkan et al., 2012; Tsai et al., 2015). Infants with
fetal growth restriction (FGR) experience a higher incidence and severity of BPD. FGR,
small for gestational age (SGA), and intrauterine growth restriction (IUGR) are all
defined as growth <10th percentile based on fetal growth curves. The Fenton Growth
Chart (Fenton & Kim, 2013) is the most inclusive growth chart for preterm infants. Data
for the Fenton Growth curve was formulated through a systematic review and metaanalysis from six developed countries among infants aged 22-36 weeks’ gestation.
Unique to this growth curve was synchronization with the World Health Organization
(WHO) Growth Standard, which extended the growth chart through 50 weeks PMA. The
WHO Growth Standard is an international standard for measuring the growth of full term,
breastfed infants, living in countries with adequate nutrition, and it is the standard for
growth assessment in the United States (The Centers for Disease Control and Prevention
[CDC], 2010). Syncing the intrauterine growth curves with the WHO growth standard
allows healthcare professionals to continue to monitor the growth of preterm infants
based on the growth of full-term infants with optimal nutrition (CDC, 2010). Based on
these details, the Fenton Growth Curve is the most comprehensive tool of growth
measurement. Infants with a birth weight of <10th percentile, per the Fenton Growth
Chart, will be considered to have FGR for this research.
Postnatal Inflammation. The systematic review of the literature identified many
biomarkers associated with inflammation due to oxygen, oxidative stress, and exposure to
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mechanical ventilation. For example, leukotriene E4 (LTE-4) is an inflammatory marker
related to damage to the cell membrane in asthma (Joung et al., 2011), and oxidative
stress was measured using 8-hydroxydeoxyguanosine (8-OHdG) (Joung et al., 2011).
However, the most common reported biomarker was brain natriuretic peptide (BNP) or
the inactive form of BNP, N-terminal-pro-BNP. BNP and N-terminal-pro-BNP measure
the same physiologic process: measurement of ventricular stretch. Both BNP and Nterminal-pro-BNP are elevated in both BPD and BPD associated pulmonary hypertension
due to hypoxia and chronic hypoxia and both are experienced by infants with BPD (Cuna
et al., 2013; Cuna et al., 2014; Harris et al., 2018; Inoue et al., 2013; Kalra et al., 2014;
Konig et al., 2016; Montgomery et al., 2016; & Rodriguez-Blanco et al., 2018). Finally,
the association of inflammation, infection, and angiogenic factors was valuable to
quantify. Neutrophil gelatinase-associated lipocalin (NGAL) was used to quantify the
intersection of infection, inflammation, and angiogenic factors in sBPD development and
found to be elevated in BPD (Capoluongo et al., 2008; Joung et al., 2011; Reicherzer et
al., 2018; & Sarafidis et al., 2008).
Given the evidence of an association with inflammation and BPD, postnatal
exposure to sources that could lead to inflammation were identified. The postnatal
exposure(s) leading to inflammation originate from several sources including exposure to
oxygen, need for mechanical ventilation (Inatomi et al., 2012; Klevebro et al., 2019;
Mailaparambil et al., 2010; Oh et al., 2005; Ohlin et al., 2015; Rutkowska et al., 2019;
Yum et al., 2018), and diagnosis of necrotizing enterocolitis (NEC), an inflammatory
bowel infection [see Table 2] (Cuna et al., 2013; Cuna et al., 2014; Harris et al., 2018;
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Inoue et al., 2013; Kalra et al., 2014; Konig et al., 2016; Montgomery et al., 2016; &
Rodriguez-Blanco et al., 2018).
Premature lungs often lack the ability to adequately exchange gasses efficiently
due to immature alveoli and lack of energy required to breathe. Therefore, mechanical
ventilation is often required to assist premature infants with their work of breathing and
gas exchange. However, there are side effects to mechanical ventilation including
pressure and volume related trauma and oxygen toxicity. Each of these exposures incur a
risk of inflammation (Abman et al., 2017; Laughon et al., 2011). When this inflammatory
process is initiated there is disruption to alveolarization and vasculogenesis, which further
interrupts adequate pulmonary growth (Mailaparambil et al., 2010). Oxygen exposure
frequently changes during each day for a preterm infant in the NICU. Therefore,
mechanical ventilation duration (total, non-invasive, and invasive) was the empirical
indicator for this variable.
NEC was defined using Bell’s Staging, the standardized assessment (Bell et al.,
1978). NEC stage 2 includes: 1) perinatal stress, 2) signs of sepsis and gross
gastrointestinal bleeding or abdominal distention, 3) abdominal radiograph demonstrating
ileus, unchanging bowel loops, pneumatosis, and/or portal venous gas. Bell’s Stage 3
included all criteria from stage 2 and: 1) signs of septic shock or marked gastrointestinal
hemorrhage, and 2) evidence of pneumoperitoneum on radiograph (Bell et al., 1978).
When measuring NEC as a variable, the studies only included patients with NEC ≥ stage
2 [see Table 2] (Bell et al., 1978). The empirical indicator for NEC was ≥ stage 2 (Bell et
al., 1978). Mechanical ventilation duration (total, non-invasive, and invasive) and a
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diagnosis of NEC ≥ Bell’s stage 2 were the empirical indicators for postnatal
inflammation.
Postnatal Infection. Methods that were used to measure infection consistently
employed the results of bacterial cultures obtained from sites of the neonate that should
be sterile (i.e., blood, spinal fluid, tracheal aspirates, and urine). A positive culture in any
of these sites was considered evidence of an infection (Ballard et al., 2016; DravetGounot et al., 2018; Durrmeyer et al., 2012; Guo et al., 2015; Klevebro et al., 2019; Lee
et al., 2011; Ohlin et al., 2015; Solimon et al., 2017; Torchin et al., 2016). Clinical sepsis,
where culture results were negative, but the patient demonstrated signs of an infection, is
also a risk factor for sBPD (Hofer et al., 2013; Ohlin et al., 2015). Measurement of
clinical sepsis was consistent between studies and included negative bacterial cultures.
Infants were assessed as having an infection when they demonstrated three or more of the
following clinical signs: respiratory compromise, cardiocirculatory compromise,
neurological compromise, poor physical color, prolonged capillary refill time, and either
hypothermia or hyperthermia. Yet another method of measuring inflammation in the
preterm neonate was with the diagnosis of NEC ≥ stage 2 (Bell et al., 1978). When
measuring NEC as a variable, the reviewed studies only included patients with NEC ≥
stage 2. For this study, there were two empiric indicators for postnatal infection: NEC ≥
Bell’s stage 2 and/or positive blood, urine, spinal fluid, or tracheal aspirate cultures.
Patent Ductus Arteriosus (PDA). PDA is a normal prenatal shunt that allows
blood flow to bypass the fetal lungs (United States National Library of Medicine, 2020).
In full term infants the PDA typically closes by 72 hours of life, but closure of the PDA is
delayed among preterm infants. Time to PDA closure is inversely related to gestational
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age; the delay is significantly longer among very preterm infants. Therefore, a PDA is not
considered an unexpected structural heart defect in preterm infants.
PDA closure requiring treatment is also more common among preterm infants
(Benitz, 2016). In the systematic review of the literature, diagnosis of a PDA was
associated with developing BPD (Dravet-Gounot et al., 2018; Demirel et al., 2009; Guo
et al., 2015; Rutkowska et al., 2019; Torchin et al., 2016). Further, a PDA that required
surgical closure was also associated with developing BPD (Durrmeyer et al., 2012;
Mailaparambilel et al., 2010). PDA increases pulmonary pressure and the amount of fluid
in the interstitium, which leads to pulmonary edema. This frequently leads to prolonged
respiratory support or increased respiratory support needs. However, none of these
identified risks play a causative role of BPD development. Instead they may be markers
for severity of the infant’s condition and the injury induced due to pulmonary edema
(Clyman, 2013). PDA data was first classified as either present or not present (diagnosed
by echocardiography). If an infant was diagnosed with a PDA, they would be further
classified as either requiring no treatment or needing treatment to facilitate closure.
Treatment for a PDA was either medical treatment and/or surgical treatment.
Extrauterine Growth Restriction. EUGR is consistently diagnosed by assessing
growth at < 10th percentile for age according to the growth curve utilized (Ohlin et al.,
2015). The association between EUGR and the development of BPD is related to higher
energy demands and insufficient intake, leading to poor lung healing and growth
(Klevebro et al., 2019).
The Fenton Growth Chart is a more comprehensive growth chart because: 1)
thedata was derived from a systematic review and meta-analysis; 2) the data was
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collected from six developed countries; 3) the data was examined on infants from 22
weeks’ until 36 weeks’ gestation; and 4) is synchronized with the WHO Growth Standard
(Charles et al., 2019; Dravet-Gounot et al., 2018; Klevebro et al., 2019; Nyp et al., 2015;
Fenton & Kim, 2013). The benefit of syncing with the WHO growth standard includes
consistency of growth assessment, compares with full term peers, and does not
necessitate the use of a different growth chart (CDC, 2010).
NICU Care and Interventions
Doses of Surfactant. Surfactant is a lipoprotein that reduces pulmonary surface
tension (Halliday, 2008). Administration of exogenous surfactant has been standard of
care to treat RDS since 1990 (NORD, 2004). Higher numbers of surfactant dosing are
associated with the development of BPD among preterm infants (Dravet-Gounot et al.,
2018; Guo et al., 2015; Hofer et al., 2013; Torchin et al., 2016). The relationship between
BPD and surfactant dosing is likely multifactorial and includes prematurity, lack of
surfactant, and arrested lung development (Bancalari & del Moral, 2001; Demirel et al.,
2009). Empirical indicator for this variable was the total number of surfactant doses
administered to the infant.
Transfusions. Higher number of packed red blood cell transfusions was
associated with development of BPD (Demirel et al., 2009). There are several proposed
mechanisms for this association including 1) damage from excessive heme oxygenase (a
by-product from heme breakdown); 2) the role of transfusion-related acute lung injury
(TRALI); and/or 3) an acute inflammatory response that negatively impacts the lungs
(Zhang, Huang, & Lu, 2014). The empirical indicator for this variable was the total
number of packed red blood cell transfusions found in all data sources (CHND, BCH
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medical record, and/or outside medical record). While there are several types of blood
components that are transfused, the systematic review of the literature focused on the
association between BPD packed red blood cells. Therefore, packed red blood cells are
the only blood component examined in this research and will be referred to as
transfusions for the remainder of the study.
Duration of Mechanical Ventilation. Premature lungs often lack the ability to
adequately exchange gasses efficiently due to immature alveoli and lack of energy
required to do the work of breathing. Therefore, mechanical ventilation is often required
to assist premature infants with their work of breathing and gas exchange. However, there
are side effects to mechanical ventilation including pressure and volume related trauma,
and oxygen toxicity. These side effects can incur a risk of inflammation (Abman et al.,
2017; Laughon et al., 2011). Gentle forms of ventilation are a method to reduce pressure
and volume-associated trauma but implementing these strategies have not led to a
decrease in the incidence of BPD (Ehrenkranz et al, 2005; Jobe & Bancalari, 2001).
Empirical indicators for this variable was the total duration of mechanical ventilation (in
days) which included non-invasive ventilation duration (in days) and invasive ventilation
duration (also in days).
Normal Line of Defense: Bronchopulmonary Dysplasia
The normal line of defense represents the usual health state of the client (Fawcett
& Neuman, 2011). Testing this mid-range theory of BPD risk could lead to the
development of a flexible line of defense by developing interventions that could decrease
the risk of BPD. As the severity of BPD worsens, the abnormal pulmonary,
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neurodevelopmental, and growth outcomes worsen (Abman et al., 2017; Ehrenkranz et
al., 2006). A diagnosis of BPD has significant concomitant health, economic, and societal
costs (Abman et al., 2017; Laughon et al., 2011), thus identification of those at risk is
critical.
The most recent and applicable BPD risk assessment tool includes gestational age,
birth weight, oxygen concentration, respiratory support, race/ethnicity, and sex. These
components determine the probability of developing no BPD, mild BPD, moderate BPD,
and severe BPD (combined types 1 and 2) (Laughon et al., 2011). To determine if the
tool was more accurate on specific days of life, it was tested on multiple days (days 1, 3,
7, 14, 21, and 28) (Laughon et al., 2011). The tool was most accurate when used on day
of life 28. While this risk assessment tool can be used, the variables of the tool do not
include all of the variables from the mid-range theory.
Long term consequences of BPD can affect the infant, family, and society
including physical, psychological, and economic impacts. The health ramifications of
BPD on infants are significant and become more significant as the grading progresses
from mild to severe. Some of these ramifications include pulmonary hypertension, poor
growth, and neurodevelopmental impairment (Abman et al., 2017). Mothers of infants
with BPD have poorer sleep quality, higher stress, and higher rates of depression (Feeley
et al., 2014). Parents of infants with severe BPD perceive their infants’ health-related
quality of life as lower when compared to parents that have full term infants or preterm
infants that do not have severe BPD (Brady, Zhang, Kirplani, & DeMauro, 2019).
Finally, the economic impact of BPD is nebulous but incurs a greater cost than that of
healthier preterm infants. There is no information on the long-term costs of BPD or the
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costs associated with comorbidities such as neurodevelopmental impairment, poor
growth, or pulmonary hypertension (Johnson, Patel, Jegier, Engstrom, & Meier, 2013;
Lapcharoensap, Lee, Nyberg, & Dukhovny, 2018).
Conclusion
The mid-range theory, as guided by the NSM (see Figure 1), highlights
extrapersonal, intrapersonal, and interpersonal stressors as represented by the empirical
indicators discussed. These stressors were associated with the development of BPD in the
systematic review of the literature. The next section of this dissertation includes a
discussion of the study aims, hypotheses, and plan for post hoc analysis if there is
sufficient sample size.
Study Aims and Hypotheses
Aim 1: To describe the sample of infants with BPD.
Aim 2: Examine the association of BPD development and the predictive variables, based
on the developed mid-range theory.
Aim 2 Hypothesis 1: The presence of BPD will be higher among male infants, born at
lower gestational ages, and born with lower birth weights.
Aim 2 Hypothesis 2: The presence of BPD will be higher for infants with fetal growth
restriction, and whose mothers were diagnosed with hypertension and chorioamnionitis.
Aim 2 Hypothesis 3: The presence of BPD will be higher for infants with multiple doses
of surfactant, multiple transfusions of packed red blood cells, and with a longer duration
of mechanical ventilation.
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Aim 2 Hypothesis 4: The presence of BPD will be higher for infants with multiple
episodes of pneumonia, sepsis, meningitis, and urinary tract infections.
Aim 2 Hypothesis 5: The presence of BPD will be higher for infants with PDA, PDA
requiring medical management, and PDA requiring surgical closure.
Aim 2 Hypothesis 6: The presence of BPD will be higher for infants with ≥ Stage 2 NEC.
Aim 2 Hypothesis 7: The presence of BPD will be higher among infants with extrauterine
growth failure.
Post Hoc Analyses
Provided that the sample was large enough, and that missing data was not an
issue, two post hoc analyses were conducted. The first sought to examine the association
between BPD and race/ethnicity, as previous research studies have had conflicting
results. The second post hoc analysis was to examine the association of each grade of
BPD (no BPD, mild BPD, moderate BPD, severe BPD type 1, and severe BPD type 2)
and the predictive variables within the mid-range theory.
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CHAPTER III
METHODS

Study Design
This cohort study was a secondary analysis of data from the Children’s Hospital
Neonatal Database (CHND) as well as data collected from Boston Children’s Hospital
(BCH) medical records and medical records from other institutions that were previously
entered into the BCH medical record. The data sought from this database were only from
infants treated at Boston Children’s Hospital, a referral center, and not a delivery
hospital. To determine the outcome and grade of BPD, data regarding mechanical
ventilation was required. Data of mechanical ventilation that was collected for the CHND
was available beginning in 2010, therefore data analysis for this study included the years
from January 2010 - January 2020. Study variables are described in Table 3. A data
abstraction tool based on the mid-range theory (see Figure 1) is shown in Table 4.
Further, a manual of definitions was employed to ensure consistency in operational
definition characterizations (Vassar & Holtzmann, 2013).
Study Sample
The CHND was analyzed with the primary inclusion criteria of being an infant
born at < 32 weeks’ gestation. Exclusion criteria included inability to determine the
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outcome of BPD and several conditions detailed in the section below (also see Table 5).
These covariates were selected based on their potential confounding effect on the
outcome of BPD.
Excluded Covariates
There are similar pulmonary signs and symptoms associated with BPD and
congenital renal disease. In congenital renal disease the pulmonary signs are typically due
to two major factors. The first factor is oligohydramnios (low amniotic fluid volume
during pregnancy), which prevents normal fetal lung development. Enlarged kidneys is
the second factor. Through their mass-effect, enlarged kidneys impede effective
ventilation and is an additional etiology for abnormal pulmonary signs and symptoms
found in infants with congenital renal disease (Rodriguez, 2014). Given these
confounding factors, infants with congenital renal disease are generally excluded in BPD
research. Infants with major congenital heart disease were also excluded. Depending on
the physiology of the diagnosis, increased pulmonary blood flow can lead to abnormal
pulmonary manifestations secondary to a cardiac etiology and not from pulmonary
disease. Therefore, infants with major congenital heart disease were excluded. Finally,
infants with neuromuscular disorders, metabolic disorders, and other major congenital
anomalies were excluded from this research. Infants with these diagnoses frequently
require mechanical ventilatory support due to poor muscular tone and/or abnormal
neurologic function (Abman et al., 2017).
Ethical Considerations
The study design was a secondary analysis of deidentified CHND data. Other
sources included data retrospectively collected from the BCH medical record and outside
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hospital records. Institutional Review Board (IRB) approval was obtained from Boston
Children’s Hospital (IRB-P00035001) and the University of Massachusetts Boston (IRB
Number 2020074). Data was electronically abstracted from CHND and entered into a
REDCap database. Data for variables that were not included in the CHND were collected
by a single data collector (the student PI) from the BCH medical record and/or the
outside hospital record. When the data retrieval was completed, each research subject was
assigned a unique identification number in REDCap. A log of subjects’ medical record
numbers and their identification numbers were stored in a separate file on a BCH
computer behind the BCH firewall. The REDCap database was stored behind the BCH
firewall in a password protected file. De-identified data was transferred in an Excel file.
Measures
As previously stated, data was obtained primarily from the CHND. When not
available in the CHND, data was collected using the BCH medical record and/or the
outside hospital records. Together they will be referred to as all data sources. If there was
a discrepancy between the CHND and the BCH medical record the outside hospital
record was reviewed to verify data accuracy.
Extrapersonal Stressor
Sex
Sex was documented in the database as either male, female, or unknown.
Race/Ethnicity
The variables for race were Asian, Black, White, American Indian, Native Pacific
Islander, other, and unknown. The variables for ethnicity include Hispanic, non-Hispanic,
and unknown.
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Interpersonal Stressors
Interpersonal risks comprised the prenatal environment and included
inflammation, infection, and MVU variables.
Prenatal Inflammation and Infection
When risk factors for BPD development were examined in a recent systematic
review, inflammation and infection were often found in concert. Clinically, inflammation
was represented by chorioamnionitis. As previously discussed, chorioamnionitis can be
diagnosed histologically and/or clinically. The database did not differentiate between
histologic or clinical chorioamnionitis. Rather, chorioamnionitis was either diagnosed or
not diagnosed for each subject. The empiric indicators for these variables were either yes
(present) or no (not present).
Maternal Vascular Underperfusion
Placental pathology was not collected as part of the data in the CHND. The
database did identify whether the mother had clinical evidence of MVU represented by
maternal chronic hypertension, gestational hypertension, HELLP syndrome, and/or
preeclampsia. The empiric indicators for this variable was either yes (present) or no (not
present).
Fetal Growth Restriction
Fetal growth restriction was assessed by plotting the birth weight on the Fenton
growth chart (Fenton & Kim, 2013) and any infant with a birth weight less than 10th
percentile considered to have fetal growth restriction, and was entered as “yes” during
data collection. If the birth weight was > 10th percentile based on gestational age, then
“no” was entered in the data collection tool.
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Intrapersonal Stressors
Intrapersonal stressors included infant characteristics (gestational age, birth
weight, patent ductus arteriosus, and extrauterine growth failure) and NICU
interventions. The NICU interventions included doses of surfactant, number of
transfusions, duration of mechanical ventilation.
Infant Demographics
Infant demographics that increase risk of BPD included gestational age, and birth
weight.
Gestational Age and Birth Weight. Gestational age was measured using
completed weeks of gestation. Birth weight was measured in grams.
Postnatal Inflammation. Risks for inflammation were represented by duration of
mechanical ventilation, due to oxidative stress, and with NEC. Duration of mechanical
ventilation was measured in number of days. NEC was measured as yes if the infant was
diagnosed with NEC (see Table 2) and if they have findings on radiograph consistent
with ≥ Bell’s Stage 2 (Bell et al., 1978). Data for NEC was categorized in the database
by the location of its occurrence, referring hospital or BCH. Medical and surgical NEC
fulfilled the requirements for Bell’s stage ≥ 2, so both variables were included in the
analysis as “yes” if diagnosed an “no” if they were not diagnosed
Postnatal Infection. Laboratory samples indicative of infection were positive
cultures. Positive blood cultures are considered diagnostic for bacteremia. Positive urine
cultures were diagnostic for urinary tract infections. Positive cerebral spinal fluid
cultures. were indicative of meningitis. Per the CHND. Pneumonia was diagnosed if the
following were demonstrated: 1) worsening gas exchange as evidenced on blood gasses;
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2) worsening appearance of the lungs on chest radiographs obtained at two different time
points; and 3) a combination of several other signs and symptoms (fever and elevated
white blood cell count, for example). Each diagnosis of infection was measured as
separate occurrences and the cumulative number of infections was used for analysis.
Patent Ductus Arteriosus. The CHND collected multiple variables for PDA.
This first included either if there is a diagnosis of PDA determined during hospitalization
or if there is no diagnosis made during hospitalization. If a diagnosis of a PDA was
determined, using echocardiography, it was further defined into other variables which
included no treatment, medical treatment, or surgical treatment. The variables collected
for this research were: 1) PDA diagnosis (yes or no), 2) treatment required for
management of the PDA, if any; and 3) what type of treatment(s) were required.
Extrauterine Growth Failure. If available, the CHND collected weights at
several time points for infants born < 32 weeks (i.e., at birth, 28 days of life, 36 weeks
PMA, 40 weeks PMA, and 44 weeks PMA). If the infant remained in the NICU at BCH,
the 50-week weight was collected, using data from the BCH medical record. Consistent
with assessing for FGR, EUGR was measured with a yes if the infant was assessed as
<10th percentile in weight for their gestational age, or no if they were not <10th percentile
for age (Fenton & Kim, 2013). Given that subjects are admitted and discharged from
BCH at different time points, the last weight collected was used to determine whether a
subject was EUGR.
NICU Interventions
Doses of Surfactant. The CHND collected whether a subject received surfactant,
or not as their surfactant variable. The other data sources were searched for the precise
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number of surfactant doses. For the purposes of this research, the total number of
surfactant doses was used as the empirical indicator for this variable
Transfusions. The CHND did not include data regarding transfusions. Therefore,
other data sources were searched for the number of transfusions administered. Due to the
wide range in the number of transfusions administered, the transfusions were grouped
into equal proportional groupings for the analysis: 1) group one received zero
transfusions, 2) group two received either one or two transfusions, 3) group three
received between three to six transfusions, and 4) group four received more than six
transfusions. A fifth group was added to account for the infants with missing transfusion
data.
Duration of Mechanical Ventilation. Duration in mechanical ventilation was
measured in total days. To further categorize mechanical ventilation data, the total
duration of mechanical ventilation was separated into non-invasive and invasive
mechanical ventilation (total days).
Normal Line of Defense
BPD Diagnosis and Grading
BPD diagnosis was determined using the diagnostic criteria developed in 2000
[see Table 1] (Jobe & Bancalari, 2001). For this research, a diagnosis of BPD was
established based on oxygen requirement at 28 days of life and respiratory support
requirements at 36 weeks ± 2 weeks.
Data Analysis
An ‘a priori’ p value for statistically significant findings was set at 0.05. Power
was set as 0.80. Statistical analysis as completed using IBM SPSS Statistics 27.
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Aim 1
The first aim was to describe the infants in the study. To describe the study
sample and determine the distribution of the sample’s data, a univariate analysis of each
concept was conducted. Gestational age and birth weight were not normally distributed,
so the median and interquartile range were reported. For race and ethnicity and sex,
frequency and percentage were reported.
Aim 2
To examine the bivariate association of BPD development (yes or no) and the
predictive variables, Chi-square test was used to examine the association between BPD
and the categorical variables (fetal growth restriction, chorioamnionitis, maternal
vascular underperfusion, patent ductus arteriosus, treatment of patent ductus arteriosus,
NEC, and extrauterine growth restriction). Wilcoxon Signed Ranks was used to test the
association between BPD and the continuous variables (doses of surfactant, number of
transfusions, duration of mechanical ventilation, episodes of infection). Bivariate analysis
and multivariate binary logistic regression were conducted to determine the association
between the outcome variable of BPD and the independent variables.
Post Hoc Analyses
Two post hoc analyses were planned, but due to insufficient representation of all
the race/ethnicity categories, only one was performed. Examining the association
between development of BPD and race/ethnicity had been conflicting in the literature
(Janevic et al., 2018). Therefore, the first post hoc analysis was planned to explore the
relationship between race, ethnicity, and BPD. However, there was insufficient
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representation of all race/ethnicity categories so this post hoc analysis could not be
performed.
The second post hoc analysis was to explore the relationship between the risk
factors and each grade of BPD (see Table 1). There were many infants in this sample that
were diagnosed with BPD, so this analysis could be performed. To examine the
association of race, ethnicity, and each grade of BPD (see Table 1) and the categorical
predictive variables, use of Chi-square test was planned. Wilcoxon Signed Ranks test was
planned to test the association between race, ethnicity, and each grade of BPD and
continuous variables. Predictive variables with p < 0.05 from the bivariate analysis was
entered into multinomial logistic regression, with the dependent variables as each grade
of BPD (see Table 1).
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CHAPTER IV
RESULTS

The purpose of this study was to examine the extrapersonal, interpersonal, and
intrapersonal stressors as identified in a systematic review that is predicted to affect the
development of BPD. The organization of the risk factors and analysis of this study was
guided by the NSM (2011), a holistic systems approach. The specific aims of this study
were to (1) describe the sample of infants with BPD in the BCH CHND and (2) examine
the association of BPD development and the predictive variables, based on the mid-range
theory (see Figure 1).
Describing the Sample
Between 2010 and 2020, there were 645 infants born at < 32 weeks’ gestation
admitted to the NICU at BCH and entered into the CHND. After identification in the
CHND, their medical records were screened following inclusion/exclusion criteria (see
Table 5). Infants were excluded if they were diagnosed with major congenital anomalies
(n=122), the presence of congenital renal disease (n=11), neuromuscular disorders (n=2),
and a metabolic disorder (n=1), or if the diagnosis of BPD could not be determined
(n=54), After screening for inclusion/exclusion criteria a final sample of 455 infants
remained (see Figure 2).
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Description of the sample of infants from the CNHC, born at <32 weeks’
gestation was completed to address Aim 1.
Frequency and percentages were used to summarize race, ethnicity, sex, FGR,
chorioamnionitis, MVU, transfusions, PDA, and NEC (Table 6 and 8). Infant weights
(measured in grams), gestational ages (measured in weeks), non-invasive mechanical
ventilation (measured in days), invasive mechanical ventilation (measured in days), and
total mechanical ventilation (measured in days) were not normally distributed, thus
median and interquartile ranges were calculated (see Table 6). Infection frequency and
percentage are presented in Table 7.
Extrapersonal Stressors
As depicted in Table 6, the ethnicity of the infant was unknown for 133 records,
and race was unknown for 96 records. Of those infants with known race and ethnicity, the
majority were white non-Hispanic, or Latino. There were more male infants than female
infants in the sample.
Interpersonal Stressors
Most pregnancies in this sample were not affected by FGR, chorioamnionitis, or
MVU (see Table 6).
Intrapersonal Stressors
Gestational Age and Birth Weight
The majority of infants in the sample were born at younger gestational ages and
had lower birth weights. The median gestational age for subjects was 26 weeks, with a
median birth weight of 820 grams (see Table 6).
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Infections
Type of infection and total infections in each subject (see Table 7) was as follows:
blood stream infections were diagnosed most frequently (27%), followed by pneumonia
(25.1%), urinary tract infections (13.2%), and meningitis (6.2%). When examined as
total number of infections per each subject, the median was 1 with IQR 0, 1;
approximately half of all subjects had at least one infection (50.8%).
Patent Ductus Arteriosus and Necrotizing Enterocolitis
Greater than half of the subjects were diagnosed with a PDA, and the majority
required medical and/or surgical treatment. There was also a group of infants that
required both medical and surgical treatment (see Table 8).
NEC was diagnosed in approximately one-third of study sample requiring medical and/or
surgical management, with the majority requiring surgical treatment (see Table 8).
NICU Interventions Required to Treat Infant Characteristics
Surfactant. The majority of infants received surfactant (77%), with a range of 0-4
doses. Most of the subjects received one dose of surfactant.
Transfusions. All data sources for each subject were searched for a history of
receiving transfusion. Of the total sample of 455 infants, data for 314 subjects was
obtained. For a more meaningful analysis because of missing data, transfusion groups
were created (see Table 9). Group one had zero transfusions (n=78), group two (n= 74)
were transfused either once or twice, group three (n=86) received between three to six
transfusions, group four (n=76) had ≥ 7 transfusions. There were 141 subjects for whom
the exact number of transfusions could not be determined despite searching all the data
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sources, A fifth transfusion group was created to include these subjects with missing
transfusion data.
Mechanical Ventilation. The days of non-invasive mechanical ventilation,
invasive mechanical ventilation, and total mechanical ventilation were not normally
distributed due to a subset of the subjects with significantly longer duration of
mechanical ventilation (see Table 6). Of those subjects requiring mechanical ventilation:
the median for non-invasive ventilation was 25 days, invasive ventilation 32 days, and
the total duration of mechanical ventilation had a median of 63 days.
Normal Line of Defense
Of the 455 subjects included in this study, 83.7% were diagnosed with BPD with
the majority diagnosed with Severe BPD [type 1 or 2] (see Table 10).
Bivariate Analysis of BPD Development and the Predictor Variables
Aim two examined the association between BPD and the predictor variables in the
study. The hypotheses were that BPD was associated with the predictive variables.
Further, it was hypothesized that variables from more than one stressor (extrapersonal,
interpersonal, and intrapersonal) would increase the risk for BPD.
First, bivariate analysis between each predictive variable and the development of
BPD were conducted. Variables with statistically significant (p < 0.05) associations with
BPD development were then entered into binary logistic regression analysis.
BPD Diagnosis and the Association with Race, Ethnicity, and Sex
Race, as a combined variable including all variables of races, did not have a
statistically significant relationship with BPD diagnosis (X2 = 11.33, df 8, N = 455, p =
0.18). There were seven categories within the race variable: White, Black/African
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American, Asian, Native American, Native Hawaiian, other, and unknown. For all of the
categories, Chi-Square analyses were performed to determine if a statistical association
with BPD existed (see Table 11). Only White (n = 218, p < 0.01) and other (n = 49, p =
0.01) were statistically significant.
The majority of subjects were not Hispanic, and this variable was found not to
have a statistically significant relationship with BPD (X2 = 5.79, df 2, N = 322, p = 0.06).
While there were more male subjects, there was no statistically significant association
between BPD and sex (X2 = 1.21, df 1, N = 455, p = 0.27).
BPD and the Association with Chorioamnionitis, MVU, and FGR
Chi-Square tests were used to examine associations between the diagnosis of BPD
and chorioamnionitis, MVU, and FGR (see Table 12). Of these conditions, FGR was the
only variable to have a statistically significant relationship with BPD (X2 =7.38, df 2, N =
81, p = 0.03).
BPD Diagnosis and the Association with Gestational Age and Birth Weight
Table 13 depicts the bivariate analysis of the intrapersonal stressors with BPD.
Using Wilcoxon Signed Ranks test for both, subjects born at lower gestational age were
more likely to develop BPD (p < 0.01), as were infants with lower birth weights (p <
0.01).
BPD Diagnosis and the Association with Surfactant, Transfusions, and Mechanical
Ventilation
The association between surfactant administration, transfusions, and duration of
mechanical ventilation were all continuous variables, so they were analyzed using the
Wilcoxon Signed Ranks. Each of the variables were statistically associated with BPD
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(see Table 13). More doses of surfactant administered was associated with the
development of BPD (p < 0.01). The number of transfusions varied from 0-41, so they
were grouped into four equal groups (group 1 with n=78, group 2 with n=74, group 3
with n=86, and group 4 with n=76). There were 141 missing data for transfusions, which
were grouped into a fifth group. Higher number of transfusions and BPD has a
statistically significant association (p < 0.01). The longer the duration of mechanical
ventilation was associated with BPD development (p < 0.01). This association was also
true for invasive and non-invasive ventilation duration.
BPD Diagnosis and the Association with Postnatal Infections
Risk for BPD and its association with pneumonia, blood stream infection,
meningitis, and urinary tract infections were analyzed using Wilcoxon Signed Ranks (see
Table13). Neither blood stream infections nor meningitis were statistically significant.
Pneumonia was associated with the development of BPD (p < 0.01), as was urinary tract
infections (p<0.01). Furthermore, the association between total number of infections and
BPD was also tested and demonstrated that increased number of infections was
associated with development of BPD (p < 0.01).
BPD Diagnosis and the Association with PDA
The association between BPD and diagnosis of a PDA was analyzed using ChiSquare test and was found to be statistically significant (X2 = 56.26, df 2, N= 455, p <
0.01). This group was further analyzed, looking at the four variables associated with a
diagnosis of a PDA: 1) no treatment, 2) medical treatment, 3) surgical treatment, or 4)
medical and surgical treatment. PDA diagnosis was examined as a categorical and
interval level variable (see Table 13). PDA diagnosis was examined as interval since each
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increasing treatment category has more implications for the infant (no treatment, medical
treatment, surgical treatment, and both medical and surgical treatment). The association
between BPD and no treatment for their PDA was not statistically significant. However,
the other three groups did demonstrate statistically significant results. First, the two
methods of treatment were analyzed. Medical treatment was associated with the
development of BPD (X2 = 36.6, df 1, N = 455, p < 0.01), as was surgical management
(X2 = 19.45, df 1, N= 455, p<0.01). Finally, the association between BPD and both
medical and surgical management was evaluated and found to be associated with the
development of BPD (X2 = 12.07, df 1, N = 455, p < 0.01). Finally, all variables of PDA
were combined, and its association with BPD was tested. The combined variable was
associated with BPD (X2 = 62.79, df 5, N = 455, p < 0.01) with a medium effect (phi =
0.44).
BPD Diagnosis and the Association with NEC
The association between a diagnosis of Stage ≥ 2 NEC and BPD was analyzed
using Chi-Square test. The diagnosis of Stage ≥ 2 NEC and BPD was statistically
significant (X2 = 20.02, df 2, N = 455, p < 0.01). Treatment of Stage ≥ 2 NEC and the
association with BPD was analyzed: 1) medical treatment, 2) surgical treatment, and 3)
medical and surgical treatment. Like PDA, NEC diagnosis was examined as a categorical
and interval level variable (see Table 13). NEC diagnosis was examined as interval since
each increasing treatment category has more implications for the infant (medical
treatment, surgical treatment, and both medical and surgical treatment). The association
between BPD and medical management was statistically significant (X2 = 3.95, df 1, N =
455, p = 0.05). The association between surgical management and BPD development was
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also statistically significant (X2 = 13.88, df 1, N =455, p < 0.01). Finally, management
with medical and surgical treatment was also found to be statistically significant (X2 =
4.06, df 1, N = 455, p = 0.04)
BPD Diagnosis and the Association with EUGR
The Independent -Sample Mann-Whitney U Test was used to analyze the
association with weight (in grams) and BPD at 28 days of life, 36 weeks’ gestation, 40
weeks’ gestation, 44 weeks’ gestation, and 50 weeks’ gestation. However, there was a
significant amount of missing data from each category. The association between EUGR
and BPD development was assessed using data from the last available weight using the
Chi-Square test. EUGR and the development of BPD was found to be statistically
significant (X2 = 20.19, df 2, N = 455, p < 0.01).
Correlation Matrix
A correlation matrix was performed to demonstrate if there were significant
correlations between the independent variables in this study. Findings demonstrated
many correlated independent variables in the study (see Table 14). There were multiple
correlated variables.
Binary Logistic Regression
The bivariate analysis of the predictor variables demonstrated that there were
significant variables in each of the extrapersonal, interpersonal, and intrapersonal
stressors. Extrapersonal stressors with p< 0.05 included variables of White and Other.
Ethnicity did not have a statistically significant relationship with development of BPD.
Of the interpersonal stressors, only FGR was statistically significant. Finally, of the
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intrapersonal stressors, many were statistically significant and evaluated further in the
regression analysis.
Table 15 depicts the results from the binary logistic regression. While variables
from the extrapersonal, interpersonal, and intrapersonal stressor categories were entered
into the analysis, only intrapersonal stressors remained statistically significant. Lower
birth weight was associated with development of BPD (OR 0.99, p = 0.04; 95% CI
[0.993, 1.00]). Patients that received more doses of surfactant were more likely to
develop BPD (OR 2.49, p <0.03; 95% CI [1.1, 5.77]). Finally, patients that were on
mechanical ventilation for longer duration were more likely to develop BPD (OR 1.2, p <
0.01; 95% CI [1.12, 1.27]).
Post Hoc Analysis
The role of race/ethnicity and the development of BPD was not further examined
since there was an insufficient representation of Black/African American, Asian, Native
American, Native Hawaiian races in the sample.
The majority of infants in this study were diagnosed with BPD (n=381, 83.7%).
More than half of those with BPD had Severe Type 1 or 2 BPD (see Table 10). The post
hoc analysis examining grades of BPD and the predictive variables was conducted. First,
a bivariate analysis was performed using Chi-square test to examine the association
between BPD grade and the categorical variables. Wilcoxon Signed Ranks test was used
to test the association between BPD grade and the continuous variables.
Bivariate Analysis of the Predictive Variables and Grades of BPD Severity
Chi-Square was used to analyze the categorical variables (see Table 16). Among
the variables of race, White (X2 =12.58, df, 4, N =455 , p = 0.01) and Asian (X2 = 17.73,
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df 4, N = 455, p < 0.01) were significantly associated with worsening severity of BPD.
The combined sample category was also statistically significant (X2 = 57.715, df 32, N =
455, p < 0.01). Among the interpersonal stressors, only FGR was statistically significant
(X2 = 29.07, df 4, N = 455, p < 0.01), with a medium effect (see Table 17). All variables
of PDA and NEC were statistically associated with severe grade of BPD (X2 = 89.34, df
16, N = 455, p < 0.01; X2 = 39.25, df 16, N = 455, p < 0.01). PDA had a large effect size
and NEC had a medium effect size. EUGR was also statistically significant with a
medium effect size (X2 =26.916, df = 4, N = 455, p < 0.01). Table 18 represents these
results.
Continuous variables were analyzed using Wilcoxon Signed Ranks. Birth weight
and gestational age were both statistically significant (U = -18.4, p < 0.01; U = -18.51, p
< 0.01). Doses of surfactant was statistically significant (U = 17.03, p < 0.01). Total days
of mechanical ventilation is a continuous variable (U = -18.237, p < 0.01). Total
infections and transfusion groups were also statistically significant (U = -17.724, p <
0.01; U = -7.13, p < 0.01).
Multinomial Logistic Regression Analysis
Multinomial logistic regression was conducted in the post hoc analysis. The
outcome variable was categorized into five categories: no BPD, mild BPD, moderate
BPD, severe BPD (type 1), and severe BPD (type 2). Independent variables with p < 0.05
from the bivariate analysis (see Tables 16, 17, and 18) were entered into the multinomial
regression analysis. Based on this analysis race, FGR, gestational age, birth weight,
doses of surfactant, total days of mechanical ventilation, total infections, transfusion
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groups, all variables of PDA, all variables of NEC, and EUGR were statistically
significant and entered into the multinomial logistic regression analysis.
Table 19 depicts the significant relationships with mild BPD included total days
of mechanical ventilation (OR = 1.16, p < 0.01; 95% CI [1.1, 1.24]), total infections (OR
0.36, p = 0.03; 95% CI [0.14, 0.9]), and NEC variables (OR = 2.17, p = 0.03; 95% CI
[1.09, 4.35]). Table 20 demonstrates the variables with significant relationships to
moderate BPD. These include doses of surfactant (OR = 2.48 p = 0.04; 95% CI [1.04,
5.89]), total days of mechanical ventilation (OR 1.15, p < 0.01; 95% CI [1.09, 1.22]),
total infections (OR 0.36, p = 0.04; 95% CI [0.14, 0.94]), and PDA variables (OR 3.35, p
= 0.01; 95% CI [1.27, 8.84]).
Table 21 demonstrates the statistically significant findings for Severe (Type 1)
BPD and the predictive variables. Variables with a statistically significant association
with Severe Type 1 BPD include gestational age, birth weight, doses of surfactant, total
days of mechanical ventilation, and all variables of PDA. Finally, Table 22 depicts the
association between Severe (Type 2) BPD and the predictive variables. Of the variables
entered in the multinomial logistic regression analysis, six were statistically significant.
The variables associated with development of Severe (Type 2) BPD included gestational
age, doses of surfactant, total duration of mechanical ventilation, and all variables of
PDA.
The only variable that was consistent across all grades of BPD was total duration
of mechanical ventilation. Total infections were associated with mild and moderate BPD.
As the grade of BPD worsens, more variables were statistically significant. For moderate,
severe type 1, and severe type 2 BPD doses of surfactant, PDA was associated with the
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development of BPD. Finally, gestational age was associated with severe type 1 and 2
BPD.
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CHAPTER V
DISCUSSION

Introduction
The sample in this study (n = 455) was treated at a Level IV NICU. All infants
treated in this NICU were transferred to the facility due to need for a higher level of care
such as a surgical procedure or a complication related to their preterm birth. This is a
select sample of preterm infants and they are among the most complex infants cared for
in the NICU. The purpose of this chapter is to interpret the findings of this research in
context of contemporary knowledge of BPD and the mid-range theory, which was
developed using the NSM (Fawcett & Neuman, 2011). The findings provide an
opportunity to improve future practice and research. Limitations to this research study are
also discussed.
Extrapersonal Stressors
The male fetus has delayed surfactant production due to hormonally based
differences which leads to an increase resistance in the alveoli and control in the budding
of the bronchioles during early fetal development (Shim et al., 2017). While male sex has
historically been a risk factor for the development of BPD (Abman et al., 2017), this was
not the case in this study. Perhaps the findings from this research demonstrate that there
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is a moderating effect due to other conditions, such as PDA or NEC that change this
long-established relationship.
Ethnicity was not statistically associated with BPD development, however
approximately one-third of subjects’ ethnicities were not reported. While the race
variables of White and other were associated with BPD development in bivariate
analysis, this relationship was not demonstrated in binary logistic regression analysis. If
there had been more subjects with race and ethnicity reported, there may have been
different results.
Interpersonal Stressors
Interpersonal stressors included chorioamnionitis, MVU, and FGR. In the
bivariate analysis, only FGR had a significant relationship with BPD. Given the
association found in the literature between chorioamnionitis and MVU, the measures
were examined in this sample. Maternal hypertensive disorders were the empirical
indicator for MVU, consistent with the literature (Mestan et al., 2014; Mestan et al.,
2017). However, other signs of MVU may include placental insufficiency, and reversal
end diastolic flow, and chronic placental insufficiency Mestan et al., 2014; Mestan et al.,
2017). As these conditions impact placental blood flow, and may impact fetal lung
development they should be included as variables in future research. Finally, it should be
noted that sufficient representation in this category of stressors may have been
underrepresented since MVU and chorioamnionitis are not typical indications for transfer
to BCH, which is a Level IV referral center and not a birth center.
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Intrapersonal Stressors
Gestational Age and Birth Weight
Generally, BPD incidence and severity increases as gestational age and birth
weight decreases. Gestational age was significantly associated with severe BPD (type 1),
and severe BPD (type 2). Birth weight was associated with a diagnosis of BPD, as well as
severe BPD (type 1). These findings are consistent with past research findings (DravetGuonot et al., 2018; Guo et al., 2015).
Surfactant
Exogenous surfactant is administered to preterm infants to bridge the gap in time
between birth and when endogenous surfactant production is sufficient to facilitate
adequate ventilation and oxygenation. The timing of endogenous production varies
depending on factors such as gestational age, maternal conditions, male sex (DravetGounot et al., 2018; Guo et al., 2015; Hofer et al., 2013; Shim et al., 2017; Torchin et al.,
2016). Objective indications for an initial surfactant dose are prematurity and symptoms
of RDS (see Table 2). Repeated doses can be administered (depending on formulation)
several more times within the first days of life for continued signs of RDS including high
oxygen requirements and high mean airway pressure. The additional doses facilitate
ventilation and oxygen needs of the premature infant (Polin & Carlo, 2014). In this study
sample, reported increased doses of surfactant were associated with a higher likelihood of
a BPD diagnosis, and specifically with moderate, severe type 1, and severe type 2 BPD.
This is consistent with previous research (Dravet-Gounot et al., 2018; Guo et al., 2015;
Hofer et al., 2013; Shim et al., 2017; Torchin et al., 2016).
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The findings from this research suggest that the relationship between exogenous
surfactant and BPD is more complex than surfactant deficiency alone. Perhaps the
requirement of exogenous surfactant dosing is less due to surfactant production
deficiency and is instead a signal for the “new BPD”, or maldevelopment of the lungs and
pulmonary microvasculature. Finally, a need for more surfactant dosing may also
represent an inflammatory or infectious etiology which prevents endogenous surfactant
production (Abman et al., 2017).
Transfusions
Transfusions are postulated to be associated with BPD through several
mechanisms including 1) damage from excessive heme oxygenase; 2) the role of
transfusion-related acute lung injury (TRALI); and/or3) an acute inflammatory response
that negatively impacts the lungs (Zhang, Huang, & Lu, 2014). The majority of subjects
received at least one transfusion, and transfusions was associated with BPD development.
The role of transfusions in BPD can be examined in two ways. The first way is
examining those infants that receive more transfusions; they are generally more ill than
those that did not require multiple transfusions. The infants that require more
transfusions are more likely to have had surgical conditions, were unable to tolerate
enteral feedings, and had less iron intake. Whether BPD is caused by transfusions or a
mark of infants with more complicated conditions are at higher risk for BPD remains to
be researched.
Mechanical Ventilation
Mechanical ventilation has been associated with BPD since 1967 (Northway et
al., 1967), and was again demonstrated in this sample. The use of mechanical ventilation
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is a necessity to support the ventilation and oxygenation of preterm infants, but also
incurs risks of oxidative injury, barotrauma, and volutrauma (Abman et al., 2017). Infants
requiring a longer duration of mechanical ventilation may be a signal of maldevelopment
in utero, that is then exacerbated by the treatment itself, and other conditions causing
inflammation and/or infection.
Patent Ductus Arteriosus
Diagnosis of PDA was made in 62.4% of the infants in this study. It is considered
a natural finding in all infants, with higher incidence and longer duration of patency
among preterm infants. Consistent with other research (Dravet-Gounot et al., 2018;
Demirel et al., 2009; Guo et al., 2015; Rutkowska et al., 2019; Torchin et al., 2016), the
findings of this study demonstrate a relationship between PDA diagnosis and
development of BPD, including the development of severe grades of BPD. Common
practice is to treat a hemodynamically significant PDA, using guidance from
echocardiography and clinical examination. Indications for treatment include a large
PDA that is not responsive to medical interventions and/or a symptomatic PDA that
causes hypotension and increased O2 requirement and increased ventilatory support.
However, waiting for signs and symptoms to occur before treating the PDA may
permit insidious pulmonary damage caused by overcirculation. Instead of waiting for
signs of a hemodynamically significant PDA prior to echocardiography, closer
surveillance, such as echocardiography and/or brain natriuretic peptide (BNP)
measurement should be considered. More research is needed to determine when a PDA is
no longer a naturally occurring condition and becomes harmful. The findings from this
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research suggest that the impact of the PDA and its role in the development of BPD
among premature infants deserves further exploration.
Necrotizing Enterocolitis and Infections
Pneumonia, urinary tract infections, and total number of infections were
associated with the development of BPD in the bivariate analysis, but not in the binary
logistic regression analysis. Total infections were associated with the development of
mild and moderate BPD in the post hoc analysis. Subjects with NEC were more likely to
develop BPD. Demonstrating the role of inflammation and infection in the development
of BPD. Infection and NEC surveillance must continue as standard of care. Further, if
infections and/or NEC are diagnosed, early BPD detection and risk reduction must be
employed.
Clinical sepsis, where the bacterial culture results were negative, but the patient
demonstrated signs of an infection, has been highlighted as a risk for BPD (Hofer et al.,
2013; Ohlin et al., 2015). Perhaps inclusion of cases of clinical sepsis would be useful in
future research to explore the role of its associated inflammation.
Extrauterine Growth Restriction
EUGR is defined as weighing < the 10th percentile for age (Ohlin et al., 2015),
and this variable was associated with BPD in bivariate analysis but not in binary logistic
regression, nor in multinomial regression analysis. While reviewing the last weight,
which was used to determine EUGR, only those weights that were in the < 10th percentile
classified EUGR. However, there were subjects whose weights decelerated significantly
over the time between birth and the final assessment. There are two considerations for
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discussion: 1) what are the reasons for the decelerations in growth, and 2) is there a more
comprehensive assessment to categorize extrauterine growth restriction?
Growth restriction is an imbalance of metabolic demands and nutritional intake.
Conditions associated with high metabolic demands include respiratory distress,
infections, NEC, PDA, and more. Nutritional intake is in the form of parenteral and/or
enteral nutrition, however providing nutritional intake to meet the dynamic needs of
NICU patients is a challenge. The balance between metabolic demands and intake needs
further exploration in the future. Comparing outcomes, using growth to define the groups,
would aid in delineating the role of growth in outcomes, specifically the development of
BPD.
Next, the most appropriate measure for EUGR deserves further exploration. As an
example, if an infant is born in the 75th percentile and then their weight decelerated to the
15th percentile they were not classified as having EUGR based on the measurement
selected. However, this represents a significant deceleration in growth. Failure to thrive
(FTT) is defined as a weight decline of ≥ 2 major percentiles on the growth chart at
separate points of assessment (Cole & Lanham, 2011). FTT is not a commonly applied
definition for preterm infants; instead EUGR is more common. However, examining
weight over time rather than only a one-time assessment could be an important area for
future examination as it may be a better indicator of overall wellness in this population.
Conclusion
This research was framed using the NSM, a holistic systems approach (Fawcett &
Neuman, 2011). A systematic review of the literature was conducted to explore the risk
factors for BPD. These risk factors were categorized into each of the NSM stressors:
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extrapersonal, interpersonal, and intrapersonal (see Figure 1). Initially there were 15
variables (with subcategories) that were proposed to be associated with the development
of BPD.
BPD diagnosis and each grade of BPD were associated with total duration of
mechanical ventilation. As severity of BPD increased, other variables increased risk
including gestational age, birth weight, and PDA. Variables that were associated with
BPD in bivariate analysis, but not in the regression analysis, deserve further exploration
in future research.
Implications
The “new BPD” is characterized by an arrest in lung development, simplified
alveoli, and a reduction in pulmonary microvasculature (Abman et al., 2017). The
development of this “new BPD” is multifactorial, demonstrated in the results of this
research. Pediatric research has demonstrated a complex relationship between
physiologic and psychologic stressors and the development of chronic diseases and
conditions (Hornor, 2016). There were multiple stressors from the intrapersonal stressors
that reflect risk(s) early in postnatal life (i.e., lower birth weight, gestational age, and
need for surfactant dosing). This research demonstrates that there is ongoing evolution of
the risks in the development of BPD. Multiple surfactant doses may be an early signal for
the “new BPD” rather than being indicative of profound surfactant deficiency. Perhaps
infants that require multiple doses of surfactant could benefit from early BPD reduction
efforts, such as steroid administration. Also, infants with infections and/or NEC could
benefit from early BPD reduction measures such as steroid administration. Finally,
systematic surveillance for PDA may lead to improved diagnosis of infants with early
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signs of cardiovascular alterations, such as stretching of chambers. Perhaps infants with
these signs would benefit from early closure, thus reducing risk for BPD.
Risks Without an Association with BPD
Classically BPD diagnoses are more likely among male infants. This was not the
case in this study cohort. Since the sample of subjects were transferred to BCH, they
may not represent the total population of preterm infants. While they may represent a
segment of NICU patients, these results may not be generalized to all preterm patients.
Fetal growth restriction was measured using birth weight, but perhaps there is a more
comprehensive measure such as decelerations in growth. MVU and chorioamnionitis
were not associated with BPD in any of the analyses. For MVU, it is possible that
maternal hypertension does not provide direct measure of MVU. Abnormal fetal doppler
findings such as decreased, absent, or reversed umbilical artery end diastolic blood flow
may provide a more direct measure of MVU for it is a sign of placental vascular
dysfunction with consequences to the fetus (Mestan et al., 2014; Mestan et al., 2017;
Taglauer et al., 2018). Coupling maternal hypertension and abnormal fetal doppler may
provide improved insight into the impact of MVU on the developing fetus, including its
risk for development of BPD. Further, arrest in fetal growth with abnormal fetal doppler
findings have been proposed as indicative of FGR without including weight (Torchin et
al., 2016). Chorioamnionitis impacts pregnancies that result in preterm deliveries more
than full term deliveries, with increasing incidence as gestation decreases (Fowler &
Simon, 2020). Chorioamnionitis impacted 12.5% of pregnancies in this study, however
the true impact is proposed to be between (8-50%) (Fowler & Simon, 2020). Clinical
chorioamnionitis was used to determine chorioamnionitis for this study, but histologic
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chorioamnionitis could have led to a more comprehensive determination of the impact of
chorioamnionitis on BPD diagnosis. Given that the subjects in the CHND are transferred
from outside hospitals, histologic diagnosis of chorioamnionitis may not be entered into
the CHND. Perhaps future studies can examine histologic and clinical chorioamnionitis
in relation to BPD. While the transfusions were positively associated with BPD diagnosis
and higher grade of BPD, it did not continue to have a statistically significant association
in the regression analyses. Transfusions may be related to comorbidities.
Limitations
There are several limitations to this study. The data in this study was obtained
retrospectively and employed secondary analysis of the CHND. Despite an extensive
review of all data sources, there was missing data. Missing data specifically impacted
transfusions, race, and ethnicity variables. BCH was not the birth hospital, rather infants
were transferred to BCH for management of other conditions such as NEC, PDA, and
extreme prematurity. Therefore, the population treated at BCH is not generalizable to the
total population of premature infants. This is a sample at a Level IV center, so results
may only be generalized to other preterm patients cared for at Level IV NICUs.
Future research
This research revealed several opportunities for future research. Measurement of
EUGR was based the Fenton Growth Chart the most consistent measure in the literature
(Fenton & Kim, 2013). However, there may be a superior method such as examining not
only the weight on a growth chart at a single point, but rather pattern of weight gain or
loss. Perhaps using the definition of FTT (weight decline of ≥ 2 major percentiles on the
growth chart at separate points of assessment) would be more meaningful (Cole &
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Lanham, 2011). Examining MVU more comprehensively, such as patterns of placental
blood flow and maternal hypertension would be more comprehensive to fully assess
MVU. Finally, testing an updated risk assessment tool that includes the additional
variables from this research may lead to more comprehensive diagnosis of each grade of
BPD.
Professional Practice Implications
The purpose of this research was to examine the risk factors for BPD as identified
in the developed mid-range theory (see Figure 1). With such significant health, economic,
and societal costs, identifying infants at risk and targeting interventions to reduce BPD
are critical (Abman et al., 2017; Laughon et al., 2011). The normal line of defense
represents the usual health state of the client (Fawcett & Neuman, 2011). Findings from
this research can be used to implement surveillance and/or preventative management for
BPD, thus establishing the Normal Line of Defense for these fragile infants.
The most recent and applicable BPD risk assessment tool includes gestational age,
birth weight, sex, race/ethnicity, postnatal day (maximum of 28 days), ventilator type,
and oxygen requirement (Laughon et al., 2011). These risk assessment variables were
validated through this research however the addition of number of surfactant
administrations, diagnosis of NEC, number of postnatal infections, and presence of PDA
may help to more accurately predict the development and severity of BPD.
The Normal Line of Defense
Improving the survival and health of infants has been a national focus since 1963,
Despite improvements in preterm infant survivability, BPD continues to be a formidable
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threat. Identification of infants through a BPD risk assessment is critical so risk reduction
efforts can be implemented thus improving the health of preterm survivors.
This research demonstrated the need to add several variables to the current risk
assessment tool including surfactant administration, a diagnosis of NEC, postnatal
infections, and PDA. Further, understanding the stressors and identifying infants at risk
may lead to risk reduction and treatment strategies that can be targeted to prevent BPD.
Risk reduction strategies such as early postnatal steroid administration (Clauss et al.,
2020) could be implemented for infants that require more than one dose of surfactant and
those with postnatal infection(s). Further, the role of PDA and incorporating early
systematic surveillance to the care for preterm infants requires examination.
Opportunities exist to intervene earlier if damage from over circulation into the lungs can
be diagnosed prior to the onset of significant injury. These risk reductions strategies
described, provide just a couple examples of the treatment strategies for BPD prevention.
With innovation and research perhaps these strategies will be replaced with more
advantageous methods of prevention not long into the future.
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Appendix 1
Table 1 Criteria for Diagnosis of Bronchopulmonary Dysplasia
Table 1
Criteria for diagnosis of bronchopulmonary dysplasia (BPD)

Bronchopulmonary
Dysplasia (BPD)

Definition
Varying severity.
Generally defined
as any O2
requirement at 28
days of life for
infants born <32
weeks gestation. It
is diagnosed at 36
weeks corrected
GA (Abman et al.,
2016)

Subcategories
Mild: O2
treatment at
least 28 days, in
room air at 36
weeks or at
discharge*
Moderate: O2
treatment at
least 28 days
and < 30% O2
at 36 weeks or
discharge*
Severe (type 1):
O2 treatment at
least 28 days
and on ≥30%
O2 or nasal
CPAP/HFNC at
≥ 36 weeks
CGA
Severe (type 2):
O2 treatment at
least 28 days
and on
mechanical
ventilation at ≥
36 weeks CGA

Incidence
Mild 30.3%

Moderate 30.2%

Severe 16.4%

Abman et al., 2017
Note: 23.1% of infants born <32 weeks’ gestation have no BPD
CPAP (continuous positive airway pressure) and HFNC (high flow nasal cannula)
*whichever occurs first
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Table 2 Operational Definitions
Table 2
Operational Definitions
Extrauterine growth restriction

Weight less than 10th percentile for age

(EUGR)
Necrotizing enterocolitis

Neurodevelopmental impairment

Patent ductus arteriosus (PDA)

Postmenstrual age (PMA)

A disorder of ischemic necrosis of the
intestine, predominantly found in very
preterm infants.
Stage 1: signs of sepsis, feeding intolerance,
abdominal distention, occult blood in the
stool
Stage 2: signs from Stage 1 plus abdominal
radiographs demonstrating rigid bowel loops,
pneumatosis, portal venous gas
Stage 3: signs from Stage 1 and 2 plus signs
of shock and abdominal radiographic
evidence of bowel perforation
Represents a wide variety of manifestations
such as cerebral palsy, cognitive delay, and
more.
A ductus arteriosus is a vascular connection
shunting blood from the lungs to the systemic
vascular system in the fetus. A PDA occurs
when this fails to close postnatally.
Gestational age plus time elapsed at birth

Pulmonary hypertension

Elevated pulmonary pressure and manifesting
with hypoxia. Can develop among infants
with BPD. Associated with more complex
hospitalizations, higher costs, and increased
risk for morbidity.
Respiratory distress syndrome (RDS)
A syndrome found in preterm infants related
to surfactant deficiency, leading to increased
work of breathing and varying respiratory
support requirements.
Surfactant
A soapy substance that reduces surface
tension in the lungs. It is deficient in preterm
infants due to lung immaturity, leading to
Respiratory Distress syndrome.
Abman et al., 2017; Bell et al., 1978; Glass et al., 2015
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Table 3 Study Variables
Table 3
Study Variables
Category
Extrapersonal
stressors
(Sociodemographic)

Variables
Description
Race
and Black mothers are more likely to experience
ethnicity
preterm births (CDC, 2016), but the role of
race/ethnicity and the development of BPD is
conflicting.
Sex
Male infants have an increased risk for developing
BPD (Northway et al., 1967; Lal et al., 2018a).
Interpersonal
Inflammation
Prenatal inflammation is evidenced by
stressors (Prenatal
inflammatory changes in the placenta (Redline,
risks)
2006). Chorioamnionitis is a maternal infection
that causes inflammatory changes in the placenta
(Kim et al., 2008; Ogihara et al., 2006; Rocha et
al., 2012).
Infection
Chorioamnionitis is a prenatal infectious process
that increases risk for BPD (Arayici et al., 2014;
Ballard et al., 2016; Kibel et al., 2016; Lee et al.,
2011; Mestan et al., 2014; Solimon et al., 2017).
Maternal
Maternal hypertensive disorders cause maternal
vascular
vascular underperfusion and increase the risk for
underperfusion BPD and BPD associated pulmonary hypertension
(Mestan et al., 2014; Mestan et al., 2017; Solimon
et al., 2017; Torchin et al., 2016).
Fetal growth restriction is defined as fetal growth
at < 10th percentile for gestational age, fetal
growth restriction is associated with maternal
vascular underperfusion. It is defined using birth
weight, and it is related to the development of
BPD (Charles et al., 2019).
Intrapersonal
Infant
There is an increased risk for development of BPD
stressors
demographics as gestational age decreases (Binet et al., 2012;
(Postnatal risks)
Dravet-Gounot et al., 2018; Mestan et al., 2014;
Torchin et al., 2016; Tsai et al., 2015).

Inflammation

Lower birth weights are associated with BPD
development (Dravet-Guonot et al., 2018; Guo et
al., 2015).
Mechanical ventilation and oxygen exposure
contribute to inflammatory changes and increase
the risk for BPD (Inatomi et al., 2012; Klevebro et
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Infection

Doses of
surfactant

Transfusions
of packed red
blood cells
Patent ductus
arteriosus
(PDA)

Extrauterine
growth
restriction

al., 2019; Mailaparambil et al., 2010; Oh et al.,
2005; Ohlin et al., 2015; Ozkan et al., 2012;
Rutkowska et al., 2019; Yum et al., 2018).
Necrotizing enterocolitis is an inflammatory
bowel infection and is associated with BPD
development (Janevic et al., 2018; Ozkan et al.,
2012).
Postnatal infections are represented by positive
bacterial cultures from blood, spinal fluid, tracheal
aspirates, and/or urine (Ballard et al., 2016;
Dravet-Gounot et al., 2018; Durrmeyer et al.,
2012; Guo et al., 2015; Klevebro et al., 2019; Lee
et al., 2011; Ohlin et al., 2015; Solimon et al.,
2017; Torchin et al., 2016). A diagnosis of
necrotizing enterocolitis will also be considered
an infection (Bell et al., 1978).
Higher doses of surfactant is associated with a
risk for BPD development ((Dravet-Gounot et
al., 2018; Guo et al., 2015; Hofer et al., 2013;
Torchin et al., 2016).
Higher volume of packed red blood cell
transfusions is associated with an increased risk
for BPD development (Demirel et al., 2009)
Presence of a PDA, and whether medical or
surgical closure is required, is associated with an
increased risk for BPD (Dravet-Gounot et al.,
2018; Demirel et al., 2009; Guo et al., 2015;
Rutkowska et al., 2019; Torchin et al., 2016).
Postnatal growth measured at < 10th percentile for
gestational age is associated with development of
BPD ((Ohlin et al., 2015).
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Table 4 Data Abstraction Tool
Table 4
Data Abstraction Tool
Socio-demographic

Interpersonal
stressors
(Prenatal risks)

Ethnicity

Hispanic

Race

Select:

Fetal growth
restriction (< 10th
percentile for age
using Fenton & Kim,
2013)
Chorioamnionitis

Yes
No
Unknown
Asian
Black
White
American Indian
Native Alaskan
Native Pacific
Islander
Other
Unknown
Yes

Select
No

Select

Yes
No

Maternal hypertensive Select
disorder (MVU)

Yes
No

Intrapersonal
stressors
(Postnatal)

Gestational age
Birth weight
Sex

Completed
weeks
Weight (grams)
Select

Doses of surfactant*

Number

Number of
transfusions*

Number

Duration of
mechanical
ventilation

Number of days
Key date of 36
weeks (if
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Male
Female
Unknown

(days collected
starting in 2010 and
minutes in 2016)

admitted prior to
key date) look at
support on that
date, and that
gives diagnosis)
If < 32 weeks
and admitted
after key date,
they need to be
on respiratory
support for > 28
days and if they
meet that
criteria, the days
of ventilation are
counted.

Episodes pneumonia*

Cut off at 36
weeks ± 2
weeks.
Number

Episodes of blood
stream infection*

Number

Episodes of
meningitis*
Episodes of urinary
tract infections*

Number
Number
Diagnosis of
PDA
If Yes PDA:

Patent ductus
arteriosus

Necrotizing
enterocolitis ≥ Bell’s
Stage 2 (Bell et al.,
1978)

Diagnosis of
NEC
If Yes NEC

Weight*

28 days (grams)
36 weeks
(grams)
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Yes
No
No treatment
Medical treatment
Surgical treatment
Yes
No
Medical NEC
Surgical NEC:
Drain placement or
Open abdomen
Recurrent NEC

Extrauterine growth
restriction (Fenton &
Kim, 2013)

40 weeks
(grams)
44 weeks
(grams)
50 weeks
(grams)
Select

Select

Yes
No

Yes
No
Diagnosis of BPD
Grading (select) None
Mild
Moderate
Severe Type 1
Severe Type 2
*Denotes data that may be obtained in the Boston Children’s Medical Record
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Table 5 Inclusion and Exclusion Criteria
Table 5
Inclusion and Exclusion Criteria
Inclusion
Birth at < 32 weeks’ gestation

Exclusion
Major congenital anomalies (excluding
PDA)
Congenital renal disease
Outcome of BPD cannot be determined
based on data
Neuromuscular disorders
Metabolic disorders
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Figure 2 PRISMA Diagram

Identification

Records identified in the CHND
for potential inclusion
(n = 645)

Screening

`

Records screened
(n = 645)

Records excluded (n =190)

Eligibility

Major congenital anomaly (n= 122)
Outcome of BPD cannot be determined (n=54)
Congenital renal disease (n=11)
Neuromuscular disorders (n=2)

Included

Metabolic disorders (n=1)

Records included
(n = 455)
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Table 6 Description of the Sample
Table 6
Description of the Sample
Variable
Sex
Male
Female
Ethnicity
Hispanic or Latino
Not Hispanic or Latino
Unknown
Race
White
Black/African American
Asian
Native American/Alaskan
Native Hawaiian/Pacific Islander
Other
Unknown
Fetal growth restriction
Yes
No
Missing
Chorioamnionitis
Yes
No
Missing
Maternal vascular underperfusion
Yes
No
Missing

Frequency (n) Percentage (%)

Variable
Gestational age (completed weeks)
Birth weight (grams)
Mechanical ventilation
Non-invasive mechanical ventilation
(days)
Invasive mechanical ventilation (days)
Total mechanical ventilation (days)

284
171

62.4
37.6

48
274
133

10.5
60.2
29.2

218
78
18
1
0
49
96

47.9
17.1
4
0.2
0
10.8
21.1

81
369
5

17.8
81.1
1.1

57
394
4

12.5
86.6
0.9

116
336
3

25.5
73.8
0.7

Median
26
820

Interquartile Range
25, 28
650, 1090

25

10, 44

32
63

8, 61
25, 91
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Table 7 Infections
Table 7
Infections
Number of infections
Pneumonia
0
1
2
3
6
Missing
Blood stream infection
0
1
2
3
Missing
Meningitis
0
1
2
Missing
Urinary tract infections
0
1
2
Missing
Total infections
0
1
2
3
4
9
Missing

Frequency (n)

Percent (%)

341
73
33
5
1
2

74.9
16
7.3
1.1
0.2
0.4

332
99
19
3
2

73
21.7
4.2
0.7
0.4

427
25
1
2

93.8
5.5
0.2
0.4

395
47
11
2

86.8
10.3
2.4
0.4

224
119
66
30
13
1
2

49.2
26.2
14.5
6.6
2.9
0.2
0.4
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Table 8 PDA and NEC Diagnoses
Table 8
PDA and NEC Diagnoses
Variable
Frequency (n)
PDA diagnosis
Yes
284
No
169
Unknown
2
PDA medical treatment
Yes
194
No
261
PDA surgical treatment
Yes
101
No
354
PDA medical and surgical treatment
Yes
65
No
390
NEC diagnosis
Yes
151
No
303
Unknown
1
NEC medical treatment
Yes
72
No
383
NEC surgical treatment
Yes
99
No
356
NEC medical and surgical treatment
Yes
20
No
435

78

Percentage (%)
62.4
37.1
0.4
42.6
57.4
22.2
77.8
14.3
85.7
33.2
66.6
0.2
15.8
84.2
21.8
78.2
4.4
95.6

Table 9 Transfusion Groups
Table 9
Transfusion Groups
141 missing
Transfusion
groups

Group
Group 1
0 (78)
Group 2
1-2 (74)
Group 3
3-6 (86)
Group 4
7 and > (76)

Total

BPD
No
45

Yes
33

Total
78

16

58

74

6

80

86

1

75

76

68

246

314

Table 10 BPD Diagnosis and Grading
Table 10
BPD Diagnosis and Grading
Variable
BPD diagnosis
Yes
No
Grade
Mild
Moderate
Severe (type 1)
Severe (type 2)

Frequency (n)

Percentage (%)

381
73

83.7
16.3

70
54
168
90

15.4
11.9
36.9
19.8
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Table 11 Bivariate Analysis of the Extrapersonal Stressors and BPD
Table 11
Bivariate Analysis of the Extrapersonal Stressors and BPD
BPD Diagnosis
Yes
No
n (%)
n (%)

Variable
Race
White
172 (78.9)
46 (21.1)
Asian
14 (77.8)
4 (22.2)
Black/African American 68 (87.2)
10 (12.8)
Other
47 (10.3)
2 (0.4)
Unknown
84 (87.5)
12 (12.5)
Native Alaskan
1 (100)
0 (0)
Ethnicity
Hispanic/Latino
46 (95.8)
2 (4.2)
Not Hispanic/Latino
225 (82.1)
49 (17.9)
Unknown
110 (82.7)
23 (17.3)
Sex
Female
139 (81.3)
32 (18.7)
Male
242 (85.2)
42 (14.8)
There were zero Native Hawaiian/Pacific Islander
Row percentage was reported here.
Race categories are not mutually exclusive
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X2(df)

p value

7.19 (1)
0.49 (1)
0.82 (1)
5.98 (1)
1.27 (1)
0.2 (1)
5.79 (2)

<0.01
0.49
0.37
0.01
0.26
0.66
0.06

1.21 (1)

0.27

Table 12 Bivariate Analysis of the Interpersonal Stressors and BPD

Table 12
Bivariate Analysis of the Interpersonal Stressors and BPD

Variable
Chorioamnionitis
Maternal vascular
underperfusion
Fetal growth restriction

BPD Diagnosis
Yes
No
n (%)
n (%)
51
6
100
16

X2(df)
1.76 (2)
0.53 (2)

p value
0.42
0.53
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7.48 (2)

0.03

5
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Table 13 Bivariate Analysis of the Intrapersonal Stressors and BPD
Table 13
Bivariate Analysis of the Intrapersonal Stressors and BPD
Continuous Variables
Variable
Gestational age (weeks)
Birth weight (grams)
Non-invasive MV (days)
Invasive MV (days)
Total days MV (days)
Total infections
Surfactant
Categorical Variables

Variable
Transfusions
0 transfusions
1-2 transfusions
3-6 transfusions
≥ 7 transfusions
NEC categories
No NEC
Medical NEC
Surgical NEC
Medical and Surgical NEC
PDA categories
No PDA
PDA, no treatment
Medically treated PDA
Surgically treated PDA
Medically and surgically treated PDA
Extrauterine growth restriction
U is standardized test statistic

Median
26
820
25
32
63
1
Median
1

IQR
25, 28
650,
1090
10, 44
8, 60.8
29, 91
0, 1
IQR
1, 2

BPD Diagnosis
Yes
No
n (%)
n (%)
33
58
80
75
240
46
75
20
45
115
122
35
64
228

Mechanical ventilation (MV)
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SD
2.93
348.38

Z
-18.52
-18.4

p value
<0.01
<0.01

23.37
44.34
46.85
1.14
SE
931.74

-17.37
-16.62
-18.22
-13.7
U
7.2

<0.01
<0.01
<0.01
<0.01
p value
<0.01

X2(df)
89.16

p value
<0.01

21.73

<0.01

60.41

<0.01

20.2

<0.01

45
16
6
1
63
6
4
0
9
56
7
1
1
24

Table 14 Correlation Matrix
Table 14
Correlation Matrix

GA
BW
Surf

Tran
s
Tota
l
MV
PNA

BSI

Men
.
UTI

Tota
l Inf
Tran
s
Grps
NEC
All
PDA
All

1
1
.76
**
.35
**
.33
**
.58
**
.23
**
.22
**
.05
**
.11
**
.31
**
.63
**
.28
**
-.4
**

2

3

4

5

6

7

8

9

10

11

12

13

1
-.32
**

1

-.31
**

.24
**

1

-.58
**

.38
**

.45
**

1

-.27
**

.17
**

.20
**

.53
**

1

-.17
**

.05

.17
**

.13
**

.02

1

.00

.00

.04

.02

.01

.17
**

1

-.15
**

.09

.22
**

.25
**

.05

.21
**

.02

1

-.31
**

.17
**

.3
**

.49
**

.66
**

.65
**

.31
**

.52
**

1

-.54
**

.31
**

.63
**

.65
**

.29
**

.29
**

.1

.29
**

.46
**

1

-.2
**

.08

.29
**

.14
**

.03

.28
**

.03

.23
**

.22
**

.47
**

1

-.33
**

.21
**

.16
**

.24
**

.12
*

.04

-.06

.07

.11
*

.32
**

.12
**
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1

**Correlation is significant at the 0.01 level (2-tailed)
*Correlation is significant at the 0.05 level (2-tailed)
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Table 15 Binary Logistic Regression Analysis of the Predictive Variables and BPD
Table 15
Binary Logistic Regression Analysis of the Predictive Variables and BPD

Independent
Variables
Gestational
age (weeks)
Birth weight
(GA)
FGR
Doses of
surfactant
Total days of
mechanical
ventilation
Total
infections
EUGR
Transfusion
groups
Race:
population
PDA
(categorical)
PDA
(interval)
NEC
(categorical)
NEC
(interval)

Univariate Logistic Regression
OR (95% CI)
P value

Multivariate Logistic Regression
OR (95% CI)
P value

0.39 (0.32, 0.48)

<0.01

1.29 (0.741, 2.25)

0.37

0.99 (0.99, 0.99)

<0.01

0.99 (0.99, 1)

0.04

3.4 (1.34, 8.81)
3.86 (2.57, 5.79)

0.01
<0.01

0.59 (0.07, 5.09)
2.49 (1.07, 5.77)

0.64
0.03

1.18 (1.13, 1.23)

<0.01

1.19 (1.11, 1.27)

<0.01

2.31 (1.59, 3.37)

<0.01

0.45 (0.19, 1.03)

0.06

3.21 (1.89, 5.44)
1.8 (1.47, 2.19)

<0.01
<0.01

0.89 (0.24, 3.29)
0.89 (0.67, 1.18)

0.87
0.43

1.16 (1.04, 1.29)

0.01

8979712 (0.00)

0.99

7.2 (4,05, 12.78)

<0.01

1.55 (0.37, 6.45)

0.55

5.71 (2.99, 10.88)

<0.01

2.57 (0.84, 7.86)

0.09

3.37 (1.72, 6.6)

<0.01

2.1 (0.27, 16.08)

0.48

1.77 (1.27, 2.74)

<0.01

1.66 (0.75, 3.7)

0.22

Model fit for binary logistic regression was X2 292.77, df 18, p < 0.01
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Table 16 Bivariate Analysis of Extrapersonal Stressors by BPD Grade
Table 16
Bivariate Analysis of Extrapersonal Stressors by BPD Grade

Variable
Race

n (%)

BPD Grade
Mild Moder Severe
ate
(type
1)
n (%) n (%)
n (%)

White

45
(61,6)
10
(13.7)
4 (5.5)

36
(51.4)
12
(17.1)
0 (0)

29
(53.7)
9
(16.7)
0 (0)

0 (0)
12
(16.4)

0 (0)
14
(20)

0 (0)
8
(14.8)

None

Black
Asian
Other
Unknown
Ethnicity
Hispanic or
Latino
Not Hispanic or
Latino
Unknown
Sex
Male
Female

2 (2.7)
49
(67.1)
22
(30.1)
42
(57.5)
31
(42.5)

8
(11.4)
40
(57.1)
22
(31.4)
39
(55.7)
31
(44.3)

6
(11.1)
27
(50)
21
(38.9)
31
(57.4)
23
(42.6)

86

76
(45.2)
25
(14.9)
14
(8.3)
1 (0.6)
35
(20.8)
20
(11.9)
104
(61.9)
44
(26.2)
111
(66.1)
57
(33.9)

Severe
(type 2)
n (%)

32
(35.6)
22
(24.4)
0 (0)
0 (0)
27 (30)

X2 (df)
57.72
(32)
12.58
(4)
4.6 (4)

p value
<0.01

17.73
(4)
1.71 (4)
6.58 (4)

<0.01

9.54 (8)

0.29

4.72 (4)

0.32

0.01
0.33

0.79
0.16

12
(13.3)
54
(60)
24
(26.7)
61
(64.2)
29
(32.2)

Table 17 Bivariate Analysis of Interpersonal Stressors by BPD Grade
Table 17
Bivariate Analysis of Interpersonal Stressors by BPD Grade

None

Variable
Chorioamnionitis
Maternal
vascular
underperfusion
Fetal growth
restriction

Mild

n (%) n
(%)
6
11

BPD Grade
Moderate Severe Severe
(type
(type
1)
2)
n (%)
n (%) n (%)
7

15

18

16

15

43

43

31

5

5

4

40

27

87

X2
(df)
10.37
(8)
7.62
(8)

Phi

29.07
(4)

0.15

p
value
0.24

0.13

0.47

0.25

<0.01

Table 18 Bivariate Analysis of Intrapersonal Stressors and BPD Grade

Table 18
Bivariate Analysis of Intrapersonal Stressors and BPD Grade
Variable
Gestational age
(weeks)
Birth

Median
26

IQR
25, 28

SD
2.39

Z
-18.51

p value
<0.01

820

348.38

-18.4

<0.01

Total MV (days)
Total infections

63
1

650,
1090
29
0, 1

None
n (%)

91
-18.22
1.14
-17.72
BPD Grading
Mild
Moderate Severe
Type 1
n (%)
n (%)
n (%)

<0.01
<0.01
Severe
Type 2
n (%)

Surfactant

X2 (df)
95.52
(16)

0 doses
1 dose
2 doses
3 doses
4 doses
Transfusion groups

35
31
3
2
0

0 transfusions
1-2 transfusions
3-6 transfusions
≥ 7 transfusions
NEC categories

45
16
6
1

No NEC
Medical NEC
Surgical NEC
Medical and
Surgical NEC
PDA categories

62
6
4
0

No PDA
PDA, no
treatment

8
56

17
33
16
2
0

15
13
14
7

39
6
20
5

9
38

5
33
12
3
0

8
14
13
8

43
6
4
1

9
13

88

17
71
63
11
3

9
27
40
30

106
25
30
7

19
41

phi

p
value
0.46 <0.01

6
36
32
10
3
185.22
(16)

0.64 <0.01

39.25
(16)

0.29 <0.01

89.34
(16)

0.44 <0.01

1
4
13
30

53
9
21
7

9
23

Medically treated
PDA
Surgically treated
PDA
Medically and
surgically treated
PDA
EUGR

7

14

19

56

33

1

4

4

20

7

1

5

9

32

18

24

33

30

108

60

89

26.92
(4)

0.24 <0.01

Table 19 Multinomial Regression Analysis of Predictive Variables and Mild BPD
Table 19
Multinomial Regression Analysis of Predictive Variables and Mild BPD

Independent Variables
Race: White
Race: Other
FGR
Gestational age
Birth weight
Doses of surfactant
Total days of
mechanical ventilation
Total infections
Transfusion (0)
Transfusions (1-2)
Transfusions (3-6)
Transfusions (>7)
PDA (interval)
PDA (categorical)
NEC (interval)
NEC (categorical)
EUGR

Univariate Multinomial
Regression
OR (95% CI)
p value
1.12 (0.55, 2.28) 0.75
0.16 (0.03, 0.8)
0.03
0.96 (0.26, 3.46) 0.94
0.45 (0.36, 0.56) <0.01
0.99 (0.99, 0.99) <0.01
2.47 (1.5, 4.04)
<0.01
1.16 (1.11, 1.21) <0.01

Multivariate Multinomial
Regression
OR (95% CI)
p value
0.75 (0.23, 2.46)
0.64
0.31 (0.03, 3.52)
0.35
2.22 (0.22, 22)
0.5
1.08 (0.61, 1.89)
0.79
0.99 (0.99, 1)
0.13
1.89 (0.83, 4.34)
0.13
1.16 (1.1,1.22)
<0.01

1.51 (0.93, 2.44)
0.19 (0.06, 0.66)
0.19 (0.06, 0.66)
0.56 (0.14, 2.22)
1.67 (0.17,
16.81)
3.27 (1.61, 6.65)
0.36 (0.18, 0.74)
2.06 (1.44, 2.95)
0.22 (0.1, 0.49)
0.55 (0.28, 1.08)

0.1
<0.01
<0.01
0.4
0.67

0.36 (0.14, 0.9)
1.06 (0.13, 8.92)
1.46 (0.2, 10.72)
2.29 (0.22, 24.35)
2.03 (0.05, 84.54)

0.03
0.96
0.71
0.49
0.49

<0.01
<0.01
<0.01
0.22
0.08

2.06 (0.77, 5.56)
0.64 (0.18, 2.3)
2.17 (1.09, 4.35)
0.28 (0.05, 1.44)
1.79 (0.44, 7.32)

0.15
0.49
0.03
0.13
0.41

For entire model: X2 629.59 (df 84), p<0.01. Goodness-of-Fit X2 1715.85 (PDA and NEC
categorical)
X2 611.67 (df 64) p< 0.01. Goodness-of-Fit X2 7422 (df 1672) p<0.01) PDA and NEC
interval)
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Table 20 Multinomial Regression Analysis of Predictive Variables and Moderate BPD

Table 20
Multinomial Regression Analysis of Predictive Variables and Moderate BPD

Independent
Variables
Race: White
Race: Other
FGR
Gestational age
Birth weight
Doses of surfactant
Total days of MV
Total infections
Transfusion (0)
Transfusion (1-2)
Transfusion (3-6)
Transfusion (>7)
PDA (categorical)
PDA (interval)
NEC (categorical)
NEC (interval)
EUGR

Univariate Multinomial
Regression
OR (95% CI)
p value

Multivariable Multinomial
Regression
OR (95% CI)
p value

0.98 (0.45, 2.11)
0.14 (0.03, 0.72)
0.92 (0.24, 3.65)
0.4 (0.32, 0.51)
0.99 (0.99, 0.99)
3.45 (2.05, 5.8)
1.17 (1.12, 1.22)
1.44 (0.86, 2.39)
0.08 (0.02, 0.3)
0.4 (0.11, 1.43)
0.99 (0.24, 4.13)
3.64 (0.35,
37.46)
0.01 (0.04, 0.22)
5.91 (2.96,
11.81)
0.69 (0.28, 1.74)
1.22 (0.79, 1.89)
0.39 (0.19, 0.81)

0.95
0.02
0.92
<0.01
<0.01
<0.01
<0.01
0.17
0.67
0.16
0.98
0.28

0.86 (0.24, 3.04)
0.23 (0.02, 2.95)
2.44 (0.22, 26.88)
1.05 (0.57, 1.93)
0.99 (0.99, 1)
2.48 (1.04, 5.89)
1.15 (1.09, 1.22)
0.36 (0.14, 0.94)
1.44 (0.15, 14)
2.84 (0.35, 23.43)
3.28 (0.29, 36.39)
4.1 (0.09, 188.17)

0.82
0.26
0.47
0.87
0.11
0.04
<0.01
0.04
0.75
0.33
0.33
0.47

<0.01
<0.01

0.16 (0.04, 5.9)
3.35 (1.27, 8.84)

0.01
0.02

0.44
0.37
0.01

1.2 (0.21, 6.9)
0.92 (0.42, 2.02)
0.95 (0.22, 4.05)

0.84
0.84
0.94
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Table 21 Multinomial Regression Analysis of Predictive Variables and Severe (Type 1)
BPD

Table 21
Multinomial Regression Analysis of Predictive Variables and Severe (Type 1) BPD

Variable
Race: White
Race: Other
FGR
Gestational age
Birth weight
Doses of surfactant
Total days of MV
Total infections
Transfusion (0)
Transfusion (1-2)
Transfusion (3-6)
Transfusion (>7)
PDA (categorical)
PDA (interval)
NEC (categorical)
NEC (interval)

Univariate Multinomial
Regression
OR (95% CI) P value
1.67 (0.94,
0.08
2.98)
0.31 (0.07,
0.13
1.42)
0.24 (0.9,
<0.01
0.63)
0.38 (0.31,
<0.01
0.47)
0.99 (0.99,
<0.01
0.99)
4.79 (3.05,
<0.01
7.51)
1.22 (1.17,
<0.01
1.28)
2.44 (1.62,
<0.01
3.68)
0.02 (0.01,
<0.01
0.05)
0.14 (0.05,
<0.01
0.41)
0.54 (0.15,
0.33
1.88)
2.42 (0.27,
0.43
21.64)
0.01 (0.05,
<0.01
0.19)
6.44 (3.33,
<0.01
12.47)
0.3 (0.15,
<0.01
0.62)
1.67 (1.18,
<0.01
2.38)
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Multivariable Multinomial
Regression
OR (95% CI)
P value
1.27 (0.36, 4.47)
0.71
0.9 (0.07, 11.49)

0.94

1.02 (0.1, 10.28)

0.98

2.07 (1.13, 3.79)

0.02

0.99 (0.99, 0.99)

0.01

2.61 (1.09, 6.23)

0.03

1.23 (1.16, 1.31)

<0.01

0.44 (0.17, 1.11)

0.08

0.42 (0.04, 4.14)

0.45

0.88 (0.11, 7.21)

0.91

1.34 (0.13, 14.39)

0.81

1.34 (0.03, 59.75)

0.88

0.19 (0.05, 0.73)

0.02

3.77 (1.39, 10.2)

<0.01

0.49 (0.09, 2.76)

0.42

1.51 (0.72, 3.16)

0.28

EUGR

0.27 (10.15,
0.49)

<0.01
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1.61 (0.37, 7.13)

0.53

Table 22 Multinomial Regression Analysis of Predictive Variables and Severe (Type 2)
BPD
Table 22
Multinomial Regression Analysis of Predictive Variables and Severe (Type 2) BPD

Variable
Race: White
Race: Other
FGR
Gestational age
Birth weight
Doses of surfactant
Total days of
mechanical ventilation
Total infections
Transfusion (0)
Transfusion (1-2)
Transfusion (3-6)
Transfusion (>7)
PDA (categorical)
PDA (interval)
NEC (categorical)
NEC (interval)
EUGR

Univariate Multinomial
Regression
OR (95% CI)
p value
2.66 (1.38,
<0.01
5.11)
0.41 (0.08,
0.28
2.04)
0.17 (0.06,
<0.01
0.47)
0.35 (0.28,
<0.01
0.44)
0.99 (0.99,
<0.01
0.99)
5.98 (3.67,
<0.01
9.73)
1.26 (1.21,
<0.01
1.32)
4.22 (2.72,
<0.01
6.52)
0.00 (0.00,
<0.01
0.02)
0.03 (0.01,
<0.01
0.13)
0.26 (0.07,
0.05
0.99)
2.42 (0.27,
0.43
21.64)
0.1 (0.05,
<0.01
0.21)
6.55 (3.35,
<0.01
12,84)
0.25 (0.12,
<0.01
0.55)
1.95 (1.37,
<0.01
2.78)
0.25 (0.13,
<0.01
0.47)
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Multivariable Multinomial
Regression
OR (95% CI)
p value
1.85 (0.46, 7.52)
0.39
1.13 (0.08, 16.58)

0.93

0.6 (0.05, 7.27)

0.69

2.34 (1.21, 4.5)

0.01

0.99 (0.99, 1)

0.06

3.07 (1.21, 7.79)

0.02

1.27 (1.19, 1.35)

<0.01

0.55 (0.21, 1.46)

0.23

0.32 (0.01, 7.05)

0.47

0.45 (0.04, 5.02)

0.51

0.97 (0.08, 11.83)

0.98

2.3 (0.05, 107.95)

0.67

0.16 (0.04, 0.7)

0.02

4.75 (1.69, 13.34)

<0.01

0.49 (0.08, 3.12)

0.46

1.84 (0.85, 3.9)

0.12

2.34 (0.44, 12.36)

0.32
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